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ABSTRACT

Galactooligosaccharides (GOS) are prebiotics that are being used to influence
intestinal microbiota towards health promoting, beneficial bacteria like bifidobacteria.
Natural sources of GOS are not found in suitable levels to achieve the desired health
effects so economically viable commercial production methods are important. Enzymatic
conversion of lactose to GOS through transgalactosylation is a preferred method since the
starting material is inexpensive and readily available. Enzymes used in batch production
are purified from fungal or bacterial sources or remain in whole cells cultured for GOS
production. Purified or unbound enzymes are single use whereas enzymes retained
within whole cells can potentially be used for multiple cycles. In the present study
Bifidobacteria bifidum ATCC 700541 is investigated as an organism for GOS production.
The strain was cultured using a previously successful medium for growing bifidobacteria
and the β –galactosidase activity was measured and compared to levels in purified
enzymes from A. niger and E. coli. We found that when compared to purified enzyme
activity levels the costs of a single batch reaction using whole cells is the same as using
purified enzymes. When the possibility for reusing the cells for multiple batches of GOS
production is considered whole cells by far are a more economically feasible option for
commercial production.
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SECTION

1. INTRODUCTION

The human gastrointestinal tract is a dynamic array of diverse micro-organisms
consisting of both potentially harmful and potentially beneficial bacterial species. A
major function of the colonic microbiota is to act as scavengers, harvesting the energy
stored in dietary residue that passes through the stomach and small intestine undigested.
Members of the genus Bifidobacterium, genus Lactobacilli and other beneficial bacteria
provide health benefits to their host by outcompeting potentially harmful microbiota
cohabitating the colon.

Bifidobacteria are the most abundant beneficial bacteria.

Bifidobacteria utilize indigestible sugar molecules called oligosaccharides for growth and
also ferment these sugars into vitamins and other nutrients which provide health benefits
to the host. Recent research uses diet to influence microbial populations of the gut
towards the beneficial microbiota, thereby increasing host health.

Figure 1.1 is an

overview of the major species found in the gut, their relative numbers, and potential
health effects.
One way to influence gut microbiota is through the use of probiotics and
prebiotics. Probiotics are live organisms added to foods, such as yogurt products like
Activia©, and after they are ingested they remain in the gut and provide health benefit to
the consumer. Prebiotics, on the other hand, are nutritional elements which pass the
stomach undigested thus allowing the indigenous bacteria of the gut to utilize them for
growth and the host receives the benefits. Oligosaccharides have been identified as
prebiotics for the purpose of increasing microbial numbers of such beneficial bacteria.
Oligosaccharides, such as fructo-oligosaccharides (FOS), galacto-oligosaccharides
(GOS), and inulin are naturally occurring in foods such as bananas, tomatoes, soybeans,
garlic, onions, and asparagus and also in human and bovine milk. Human milk, in
particular, is rich with GOS and comparison of nursing infants to infants fed formula
indicates GOS is essential to increasing the abundance of indigenous Bifidobacteria in
the large intestine increasing the health benefit to the host while minimizing potential
side effects. Natural sources of GOS are insufficient or inconvenient to extract for use as
health enhancing additives. A way of producing synthetic GOS is necessary to meet
demands and needs.
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Figure 1.1 Generalized Scheme and Health Effects of Predominant Human Fecal
Bacteria (Isolauri et al. 2004).

Current commercial production of synthetic GOS involves using a

-

galactosidase enzyme to convert a high concentration lactose solution to a heterogeneous
solution comprised of varying length GOS, galactose, and glucose. The feed stream for
the conversion is usually lactose whey concentrate, a by-product considered waste of the
dairy industry. Figure 1.2 illustrates an overview of a cheese making process and whey
production.

-galactosidase enzymes used for production of GOS are typically isolated

from yeasts, fungi, and other bacteria such as E. coli. Most species of Bifidobacteria
produce -galactosidase as well as -galactosidase.
The main linkage structure present in GOS converted from lactose is -galn-(1-4)-glc although other β-glycosidic linkages have been found including -galn-(l-6)- -gal,
-galn-(1-2)- -glc, -galn-(1-3)- -glc, -galn-(1-4)- -glc, -galn-(1-6)- -glc, -galn-(1-2)-gal and -galn-(1-3)- -gal. GOS not derived from lactose also include α-glycosidic
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linkages such as α -gal (1-6)2- α -glc and α -gal (1-6)2- α –gal. While there is no direct
evidence that

-linked or -linked sugars provide different benefits it is believed that

both linkage types within the GOS molecule provide health benefit to the host without the
harmless, but unwanted, side effects when they are utilized by the gut bacteria.

Figure 1.2 Overview Schematic of Cheese Processing with End Products as Cheese,
Whey Solids and Lactose.

The percent conversion of lactose to GOS depends on time, temperature, initial
lactose concentration and, as recent work has shown, enzyme source. Since reaction time
is a key factor for maximum conversion of lactose to GOS, the use of extracted enzymes
requires enzyme inactivation, usually by temperature denaturation, to end the reaction at
the optimized time. Denaturation renders the enzyme unusable so fresh enzyme must be
used for each GOS conversion batch.

In order to create a more economical GOS
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production process, promising work has been done using cells of a novel strain of
Bifidobacteria bifidum. Since the enzymes are contained within the cell structure, using
cells allows for physical removal of the enzyme source from the reaction mixture without
deactivating the enzyme and allowing recycle of the enzymes for multiple conversions.
In order for the use of whole cells to be economical a strain should be grown on
an inexpensive media using a readily available sugar as its carbohydrate source. The
culture must also reach a high cell density with desirable enzyme kinetics. Bifidobacteria
do not easily grow on a purely synthetic media. Much effort has been put towards
determining what growth factors exist and how they can be incorporated into a synthetic
media. So far, research has identified that human milk, bovine milk casein fractions and
yeast extract contain growth enhancers but the mechanism of enhancement is not known.
The biggest obstacle to determining the specifics to growth enhancement is that the
growth patterns of each Bifidobacteria, including different strains within the same
species, have drastically different results when grown under the same media conditions.
The scope and focus of this work is to investigate B. bifidum ATCC 700541 as a
potential organism for GOS production as an alternative to purified enzymes. The
organism must actively grow on a convenient, simple media and also produce significant
quantities of the -galactosidase enzyme to be useful for the production process. The galactosidase activity of the cells will also be evaluated as it has been shown that

-

linked GOS may provide additional benefit as a prebiotic agent. The kinetics of the
investigated strain of B. bifidum are compared to the kinetics of purified -galactosidase
from E. coli (Sigma Aldrich, MFCD00130623) and purified
Aspergillus niger (Deerland Enzymes).

-galactosidase from

The economics of culturing bacteria are

evaluated against the purchase of purified enzymes for use in GOS production in a batch
reaction system.
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2. BACKGROUND

2.1. PROBIOTICS AND PREBIOTICS
Live Lactobacilli and Bifidobacteria cultures ingested in pill form or added to
food products with the aim of increasing the intestinal numbers of beneficial bacteria are
known as probiotics. In 1989, probiotics were defined as live microbial feed supplements
which beneficially affect the host by improving its intestinal microbial balance (Fuller
1989). In 2001, the World Health Organization further defined a probiotic as “a live
micro-organism which when administered in adequate amounts confer a health benefit on
the host” (www.who.int/entity/foodsafety Nov 2010; Leahy et al. 2005). Establishing
change in the gut microbiota through probiotics requires passing the bacteria through the
stomach to the intestines in a viable form. In order for the probiotic organism to become
established in the intestinal tract, the cultures must remain viable during processing and
storage, resist the acidic environment of the stomach fluids, compete with existing gut
bacteria for nutrients and adhere to the intestinal wall (Fuller 1991; Isolauri et al. 2004).
Probiotic treatment requires repeated ingestion for sustained benefit since often the
organism washes out of the host when it is discontinued as part of the diet (Gibson and
Roberfroid 1995). To overcome the obstacles presented by probiotic therapy, researchers
began looking at alternatives for influencing gut microbiota towards beneficial bacteria.
The alternative to ingesting the desired organisms is to stimulate the indigenous
populations. Research shows that Bifidobacteria and Lactobacilli are capable of utilizing
food elements for growth that many gut bacteria cannot digest. A nondigestible food
ingredient that beneficially affects the host by selectively stimulating the growth or
metabolic activity of a single or limited number of bacteria imposing a health benefit
upon the host is the definition of a prebiotic (Gibson and Roberfroid 1995; Leahy et al.
2005). Based on this definition the current criteria for classifying a food component as a
prebiotic are it must: a) be able to pass through the upper gut undigested b) provide
selective fermentation by a single or limited number of beneficial bacteria in the colon c)
provoke the colonic microbiota towards a healthier composition and d) generate effects
that are beneficial to the host health (Fooks and Gibson 2002). Oligosaccharides are nondigestible carbohydrates that possess these characteristics.
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In 1999 the value of functional food additives in the U.S. was estimated at $163
million and was expected to increase by 7% annually reaching $322 million by 2009
(Reisch 2001).

With public awareness through major marketing campaigns of

commercial products such as yogurts and other fermented dairy products the market has
reached $16 billion and is expected to continue to increase at a rate of 12.6% a year the
next 5 years reaching $32.6 billion (Markets and Markets, 2009). Oligosaccharides have
emerged worldwide as the focus of a new health movement and in 2001 the U.S. Food
and Drug Administration (FDA) approved Galacto-oligosaccharides (GOS) as a dietary
ingredient (FDA, 2001).

Oligosaccharides are obtained by extraction from natural

sources or synthesized through glycosylation reactions, enzymatic hydrolysis of
polysaccharides, or transgalactosylation reactions (e.g. GOS and FOS) (Espinosa-Martos
and Ruperez 2006; Borman 2007; Hsu et al. 2007). GOS are proving to be promising
food additives in that they are stable in high temperature acidic environments and can be
added as sugar substitutes in a variety of foods including infant formulae, dairy products,
sauces, soups, cereals, beverages, snack bars, ice cream, breads, and animal feeds
(Macfarlane et al. 2008; Manning and Gibson 2004). Also, GOS has a convenient
starting material in cheese whey. Whey contains lactose and is abundantly available as a
byproduct of cheese making. After concentration, the lactose in the whey is converted to
GOS through enzymatic transgalactosylation. Using whey to produce GOS adds value
and eliminates a costly waste stream (Pruksasri 2007).

2.2. GALACTO-OLIGOSACCHARIDES (GOS)
Oligosaccharides are indigestible, multi-moiety carbohydrate molecules that pass
undigested through the stomach and small intestines into the large intestines. GOS are
oligosaccharides which contain two to five galactose molecules and a single glucose
molecule linked through glycosidic bonds.

GOS possess a molecular structure

generalized as (Galactose)n – Glucose (Sako et al. 1999). GOS are found naturally in
bananas, tomatoes, soybeans, garlic, onions, and asparagus and also human milk. The
FDA has granted GOS the generally regarded as safe (GRAS) status allowing
commercial uses for human consumption. GOS are used as additives to infant formula
and as food sweeteners with a reported caloric value of 1.75 kcal/g compared to 4.2
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kcal/g caloric value of sucrose (table sugar) (Macfarlane et al. 2008). The true value of
GOS comes from the health benefits incurred by the host when they are consumed.
2.2.1. Health Benefits of GOS. Research indicates consuming 4-8 g/day of GOS
can provide the desired health benefits. A gut with an already healthy microbial balance
will likely see little or no benefit and can possibly have the ill effect of increasing
discomfort, in particular gas and bloating (Manning and Gibson 2004). However for
individuals who gain from GOS consumption the benefits experienced are directly related
to the effect GOS has on the microbial composition in the intestine. Intestinal bacteria
have nonspecific metabolic pathways and utilize an array of sugars as carbohydrate
source for growth; however, amongst all the intestinal organisms Bifidobacteria grow at a
faster rate on GOS and convert GOS to cell mass to a greater extent (Macfarlane et al.
2008; Rycroft et al. 2001). An increased presence of Bifidobacteria has an antagonistic
effect on the pathogenic organisms in the gut by metabolic suppression and reduced toxin
release (Macfarlane et al. 2008). Consuming GOS is a treatment for diarrhea related to
food poisoning and traveler’s sickness since it promotes the growth of indigenous healthy
bacteria and in so doing makes it more difficult for pathogens to establish and survive.
Bifidobacteria prevent colonization of new pathogens by using available nutrients
keeping harmful bacteria from being able to establish a significant presence in the gut
(Isolauri et al. 2004; Leahy et al. 2005).
Intestinal microbiota is established during the birth process. Studies on infants
who are fed mother’s milk vs. those fed infant formulae show that in those which are fed
mother’s milk Bifidobacteria dominate the bacterial numbers accounting for up to 95% of
the bacterial population where those which are fed formula have bacterial profiles more
similar to an adult (Macfarlane et al. 2008). Studies also show that the Bifidobacteria
present in the breast fed infants play an important role in establishing the immune system,
protects the infant from development of allergies, and prevents bouts of acute and chronic
diarrhea. Infant formula is fortified with GOS in atempt to promote these same health
effects in infants which are not breast-fed (Isolauri et al. 2004; Leahy et al. 2005).
In adults some benefits attributed to Bifidobacteria are stimulating immunological
factors, lessening bloating caused by gas, improving digestion, aiding in absorption of
essential nutrients, increasing calcium balance, producing vitamins and digestive
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enzymes and releasing short chain fatty acids which are used for energy (Gibson and
Roberfroid 1995; Leahy et al. 2005).

Bifidobacteria inhibit growth of pathogenic

bacteria by releasing acidic metabolites (e.g. lactate and acetate) that lower the pH of the
gut making a harsher environment for survival. Some metabolites act as antimicrobial
agents directly. Amines and ammonia released when proteins are digested are protonated
by the acidic metabolites causing blood levels of toxic ammonia to decrease (Gibson and
Roberfroid 1995). Consuming GOS helps promote Bifidobacteria growth restoring the
intestinal microbial balance after the administration of antibiotics which, in elderly
patients especially, can wipe out the indigenous Bifidobacteria and Lactobacilli in
addition to the bacteria actually causing the infection. GOS are also used to correct
bowel inconsistencies (Gibson and Roberfroid 1995; Fooks and Gibson 2002). Research
is being conducted to define the role that Bifidobacteria play in the prevention of colon
cancer, irritable bowel syndrome and other colon related diseases. The extent to which
GOS consumption can benefit the consumer is an area of research that is receiving a great
amount of attention and it will be likely many years before it is fully understood.
2.2.2. Methods of GOS Production. In an adult diet or for infants not feeding
on mother’s milk it is difficult to attain through natural food sources the recommended 48 grams/day of GOS needed for the desired health benefits. Commercially produced
GOS are added as low calorie sweeteners to consumer goods such as infant formulas,
dairy products, sauces, soups, cereals, beverages, snack bars, ice cream, and breads in
order to supplement natural sources to reach the recommended daily dose (Macfarlane et
al. 2008; Manning and Gibson 2004). Methods of production include synthesis reactions
(Borman 2007), extraction from natural sources such as soybeans (Espinosa-Martos and
Ruperez 2006) and enzymatic transgalactosylation reactions to convert the high
concentration lactose solution into a mixture of GOS and other sugars. Enzymatic
conversion reactions are carried out in numerous ways and are the most utilized method
for GOS production (Sako et al. 1999). Lactose from cheese processing is the preferred
and most convenient starting material. Figure 2.1 shows the overall production scheme
using enzyme reactions for conversion of lactose to GOS.
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Figure 2.1 Industrial Production Process of GOS (Sako et al. 1999).

Enzymatic conversion can be applied as any of the following: a) Batch
production, illustrated in Figure 2.2, in which enzymes purified from either a microbial or
fungal source are added to a concentrated lactose solution, incubated, and then heated to
terminate the conversion by denaturing the enzymes (Onishi and Tanaka 1995; Splechtna
et al. 2006; Hsu et al. 2007) b) Biotransformation production, also illustrated in Figure
2.2, using whole cells containing the useful enzymes in a batch reactor. As with purified
enzymes the whole cells are added to the lactose solution and incubated.

After

incubation the solution is not heated to denature the enzymes. Instead, the cells are
removed from the solution by either filtration or centrifugation so they can be reused
(Onishi et al. 1995; Goulas et al. 2005).
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Figure 2.2 GOS Production Using a Batch Reaction with Whole Organisms or Purified
Enzymes to Convert Lactose.

c) Continuous fed-batch reaction is shown in Figure 2.3. Enzymes or whole cells are
added to a high concentration lactose solution and after incubation the mixture is
circulated through a tangential flow membrane. The enzymes or cells are retained on the
retentate side of the membrane and the sugar solution is removed as permeate. To drive
the reaction towards continuous GOS production, a high concentration lactose solution is
fed to the reactor at the same rate that permeate is leaving the system keeping the volume
in the reactor constant (Chockchaisawasdee 2005) and d) Immobilization where enzymes
or cells are entrapped in porous beads and packed in a column as shown in Figure 2.4.
Concentrated lactose solution is passed over the column where the conversion reactions
take place and the outlet stream is collected for further processing (Dey-Chyi et al. 1998;
Yang and Bednarcik 2001).
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Figure 2.3 Continuous GOS Processing Using a Tangential Flow Filtration System.

Figure 2.4 Enzymatic Conversion of Lactose to GOS Using Immobilized Enzymes or
Cells.
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In order to have an efficient process it is important to be able to convert the most
amount of lactose at the least amount of cost. If whole cells can be grown so they contain
a sufficient amount of enzyme activity then they provide opportunity for cost
effectiveness based on potential for reuse. Slow diffusion kinetics and problems with
fouling, plugging and pressure drop limit the potential for immobilization to be cost
effective. Using pure enzyme is effective for constant dosing for conversion but is costly
due to single use.
2.2.3. GOS Reaction Kinetics Using Lactose. GOS synthesis from lactose is
characterized by an initially rapid decrease in lactose concentration and is accompanied
by the formation of glucose and galactose. The final reaction product is a mixture of
monosacharides (glucose and galactose), disaccharides (lactose and allolactose),
trisaccharides and tetrasaccharides (GOS).

Figure 2.5 is a chromatographic

representation of the enzyme conversion products (Splechtna et al. 2006).

Figure 2.5 Separation by Capillary Electrophoresis of Individual GOS Products During
Lactose Conversion Catalyzed by β-Galactosidase. (1) glucose (2) galactose (3) lactose
(5) allolactose (6) Gal-Gal (7-8) Gal-Lac (x) products not identified (Splechtna et al.
2006).

13
As the conversion of lactose progresses towards 100% conversion the
concentrations of glucose and galactose continue to increase and the concentration of
GOS decreases. This reaction scheme suggests that in transgalactosylation GOS are
formed as intermediates and are subject to hydrolysis thus serving as substrates as lactose
becomes depleted. Figure 2.6 shows the reaction kinetics of lactose conversion by βgalactosidase from Bifidobacterial longum BCRC 15708 carried out at 45 °C and pH 6.8
with an initial lactose concentration of 40%. GOS concentrations increase steadily until
lactose conversion reaches about 50% then there is a sharp drop in GOS concentration
and if allowed to continue, the GOS would completely hydrolyze into galactose and
glucose (Hsu et al. 2007).

Figure 2.6 Lactose Conversion by β-Galactosidase from Bifidobacterial longum BCRC
15708. Carried Out at 45 °C and pH 6.8 with an Initial Lactose Concentration of 40%
(Hsu et al. 2007).
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Much work has been done to find conditions which maximize GOS production.
Research has shown that enzyme source, temperature, pH, hydrolysis product
concentrations and most importantly initial lactose concentration dictate GOS
concentrations during processing.

Enzyme source will determine what pH and

temperature are optimal for conversion. For example, in a study using β-galactosidase
from E. coli, the optimal pH was between 7 and 7.5 (Huber et al. 1976) whereas in a
study using β-galactosidase from Bifidobacterium longum the optimal pH was 6.8 (Hsu et
al. 2007). Most conversion reactions are run at 40 - 45 °C but some enzymes purified
from thermophilic organisms are capable of operating at higher temperatures. In general
both glucose and galactose have an inhibitory effect and decrease total GOS formation
(Hsu et al. 2007; Chockchaisawasdee et al. 2005; Onishi et al. 1995). In a study using βgalactosidase from Kluyveromyces lactis it was demonstrated that the conversion of
lactose to GOS is independent of enzyme concentration. The results of this study, as
presented in Figure 2.7 and Table 2.1, show that increasing enzyme concentration causes
the reaction to progress to the end point faster but did not impact the overall amount of
GOS present in the mixture.

Figure 2.7 Time Course of GOS Synthesis From 340 mg/mL Lactose Using Differing
Concentrations of Enzyme ((a), 2.9 U/mL, (b), 5.8 U/mL, (c), 8.7 U/mL) in a Batch
Reactor at 40 °C, pH 7 (x, lactose; Δ, glucose; □, galactose; ●, GOS)
(Chockchaisawasdee et al. 2005).
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No matter the enzyme source it is evident that at lower lactose concentrations the
hydrolysis reaction is the dominant reaction. Initial lactose determinations made using B.
longum, K. lactis, and B. bifidum all demonstrate that initial concentrations of lactose
between 40% and 50% are necessary to engage the transgalactosylation reaction of the
enzymes in order to produce GOS. The dramatic effect that changes in initial lactose
concentration has on GOS production in contrast to fluctuations in pH or temperature are
shown in Figure 2.8 (Hsu et al. 2007; Chockchaisawasdee et al. 2005; Tzortis et al.
2005).

Table 2.1 Observed GOS Concentration in a Batch Reactor Over 4 h at 40 °C at pH 7
(Chockchaisawasdee et al. 2005).
GOS Concentrations (mg/mL)
*220 mg/mL
Enzyme
lactose
Concentrations
2.9 U/mL
53

*280 mg/mL
lactose
68

*340 mg/mL
lactose
88

*400 mg/mL
lactose
96

5.8 U/mL

49

64

85

99

8.7 U/mL

45

62

81

96

* Initial lactose concentrations
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Figure 2.8 Effects of Temperature (pH 6.8, 40% lactose), pH (45 °C, 40% lactose) and
Initial Lactose Concentration (pH 6.8, 45 °C) on GOS Production Catalyzed by βGalactosidase from B. longum. (Hsu et al. 2007).

2.3. ENZYME ACTION
In the early 1950’s oligosaccharides were discovered during lactose hydrolysis
reaction studies using lactase. Figure 2.9 shows a lactose hydrolysis reaction by βgalactosidase where galactose and glucose are the hydrolysis products.
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Figure 2.9 Lactose Hydrolysis Reaction by β-Galactosidase.

In commercial production, galactosidase enzymes are the functional enzymes in
lactose conversion to GOS. In 1953 John Pazur proposed a two step process as the
mechanism for the enzymatic synthesis of GOS by β-galactosidase transgalactosylation.
The first step in Pazur’s proposed two step process is the formation of a galactoseenzyme complex and the liberation of glucose. The second step in his process is the
transfer of the galactose molecule from the galactose-enzyme complex to a cosubstrate in
the system to form the GOS molecule. Figure 2.10 illustrates the mechanism proposed
by Pazur. In his system, if the cosubstrate is glucose then complex I, allolactose, is
formed. If the cosubstrate is galactose then complex II is formed. If the cosubstrate is
lactose or allolactose then either complex III or IV, GOS, are formed. Complex III
consists of glucose β(1-6) galactose β(1-4) galactose and complex IV consists of glucose
β(1-4) galactose β(1-4) galactose (Pazur 1954). This mechanism can be extended to
continue building GOS consisting of more than three moieties.
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Figure 2.10 GOS Formation Mechanism as Proposed by Pazur (Pazur 1954).

In 1976 R.E. Huber et al. further characterized the reaction mechanisms involved
in GOS synthesis.

They showed that β-galactosidase has two transgalactosylase

functions and a hydrolysis function. The transgalactosylase functions are described as
“indirect” transgalactosylase activity and “direct” transgalactosylase activity. Indirect
transgalactosylase activity happens as Pazur describes where lactose is bound by the
enzyme, glucose is released, and the galactose releases to an acceptor molecule. Direct
transgalactosylase activity involves the binding of the lactose by the enzyme, the
cleavage of the β-(1-6) bond and the formation of a β-(1-4) bond with the same glucose
molecule forming allolactose (Huber et al. 1976).
structures of lactose and allolactose.

Figure 2.11 shows the linkage
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Figure 2.11 Lactose and Allolactose Molecules.

Juers et al. further explains the action of β-galactosidase. They suggest that βgalactosidase has two binding positions, shallow and deep binding.

β-galactosidase

hydrolyzes the substrate in a double displacement reaction with protonation of the leaving
group (glucose) being a rate limiting step. During the formation of the galactose-enzyme
intermediate complex the substrate first binds in the shallow binding position then moves
into the deep binding position of the active site and the glycosidic bond is cleaved. The
second step of the reaction is an acceptor molecule performs a nucleophilic attack on the
bound galactose forming the reaction products. In hydrolysis the acceptor molecule is
water.

In transgalactosylation the acceptor molecule is either glucose, forming

allolactose, or a di- or tri- saccharide forming GOS. Both free glucose and galactose
effect the GOS formation reaction by binding the enzyme and competitively inhibiting
the initial hydrolysis reaction (Juers et al. 2001). The extent to which the reaction is
inhibited depends on the enzyme source and other reaction conditions (Hsu et al. 2007;
Tzortis et al. 2005).
The thermodynamics of the catalysis favor hydrolysis; however, the available
alcohol groups on the carbohydrates in solution, which allow them to act as acceptor
molecules, cause GOS yield and compositions to change dramatically with reaction time.
Figure 2.12 graphs the formation and degradation of individual GOS products over time
from a lactose conversion reaction using β-galactosidase derived from Lactobacillus
reuteri. In addition to time, the composition of GOS is also highly dependent on the
source of β-galactosidase. Comparing GOS products using β-galactosidase from
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Lactobacillus reuteri, Pyrococcus and Sofolobus solfataricus shows the composition
variation between the enzyme sources and also the variation of linkages within the GOS
molecules. Typically the linkages between the monomers are β-(1-4) glycosidic bonds;
however, Table 2.2 compares the variety of glycosidic linkages in GOS in research
results and in a commercially available product.

Figure 2.12 Formation and Degradation of Individual GOS During Lactose Conversion
by β-galactosidase from L. reuteri (Initial Lactose Concentration , 205g/L). (●) total
GOS, (◘) disaccharides, ( ) trisaccharides, and (◊) tetrasaccharides. (Splechtna et al.
2006).

21
Table 2.2 Observed Glycosidic Linkages and GOS Compositions (Splechtna et al. 2006;
Petzelbauer 2001; USFDA 2001).
GOS Source and Structure*
Carbohydrate

Pyrococcus
furiosus

Sulfolobus
solfataricus

gal (1-3) glc

gal (1-3) glc

gal (1-6) glc

gal (1-6) glc

Disaccharides

Lactobacillus
reuteri
gal (1-6) glc

Commercial
GOS
gal (1-3) glc

gal (1-6) gal

gal (1-6) glc

gal (1-3) glc
gal (1-3) gal

gal (1-4) gal
gal (1-4) gal

gal (1-3) gal gal (1-3) gal gal (1-3) gal
(1-4) glc

(1-4) glc

(1-4) glc

(1-4) glc
gal (1-6) gal

Trisaccharides

(1-4) glc
gal (1-6) gal gal (1-6) gal gal (1-6) gal
(1-4) glc

(1-4) glc

(1-4) glc

gal (1-3) gal
(1-4) glc

Tetrasaccharides
and higher
oligomers

gal (1-3) gal
(1-3) gal (1-4)

gal [(1-6) gal
NA

glc

NA

(1-4)]n

gal

(1-4) glc

*All linkages are β-glycosidic bonds. Gal (1-6) Glc is allolactose.

While the health benefits directly related to GOS with α-galactosidic bonds have
not been fully investigated, an organism with α-galactosidase activity is able to utilize αlinked sugars such as raffinose and stachyose which are naturally occurring in soybeans.
The known mechanism of α-galactosidase is primarily in the hydrolysis of α-linked
oligosaccharides. However, in their investigation of α-galactosidase hydrolysis kinetics,
Konstantin et al. observed transgalactosylation activity using melibiose, an α-linked
disaccharide of glucose and galactose, resulting in the formation of GOS (Shabalin et al.
2002). Research efforts are being directed towards finding α-galactosidases capable of
synthesizing GOS for the prebiotic production.

Studies using Bifidobacteria

adolescentis, Bifidobacteria breve, and Bifidobacteria bifidum are yielding promising
results (Goulas et al. 2009a).
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The kinetic properties of both enzymes are dependent upon pH and temperature.
As described earlier, depending on the source of the enzyme the optimum conditions and
final product structure and composition vary. Huber et al. confirm the optimal pH for βgalactosidase to be between 6.5 and 7.0 (Huber et al. 1976). Jurado et al. agree and show
ideal temperatures range from 40°C to 50°C. They also establish a relationship between
the activity of β-galactosidase and the ionic concentration of the solution (Jurado et al.
2004).

2.4. BIFIDOBACTERIA
GOS and other prebiotics modify intestinal health by influencing beneficial,
health promoting bacteria.

The primary targets of prebiotics are members of the

Bifidobacterium genus and Lactobacillus genus (Macfarlane et al. 2008). Studies have
shown bifidobacteria to be the dominant players in the health and development of the
lower digestive tract microbiota in infants (Niittynen et al. 2007). Bifidobacteria have
also been shown to be key in the health of the elderly with particular attention paid to
intestinal microbiota recovery after the administration of antibiotics (Hamilton-Miller
2004; Macfarlane et al. 2008). Since bifidobacteria play such an important role in the
health of the human gastrointestinal tract and have other health related benefits much
effort is being made to characterize and understand what influences their growth.
Until recently, Bifidobacterium were known as Lactobacillus bifidus since they
demonstrated many of the same properties as members of the Lactobacillus genus.
However, bifidobacteria were found to involve the use of the enzyme fructose-6phosphate phosphoketolase in their carbohydrate metabolic pathway which is not used in
other species of Lactobacillus. In addition closer study of cell morphology, DNA and
nutritional requirements for growth revealed Bifidobacterium as its own genus. Members
of Bifidobacterium genus are gram positive, anaerobic bacteria. Bifiobacterium are a
diverse group of species which are not nutritionally homogeneous.

The nutritional

requirements and aerotolerance of each species are strain dependent. One commonality
amongst species of Bifidobacterium is they are not readily cultured on a purely synthetic
media but require a complex nutritional component, such as casein or yeast extract, for
culturing (Poupard et al. 1973; Poch and Bezkorovainy 1988).

One species of
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bifidobacteria that has been used as a probiotic and has received significant attention for
prebiotic targeting is Bifidobacteria bifidum. The interest in these strains is directly
linked to their β-galactosidase and α-galactosidase activities and how they respond to
GOS and other prebiotics in vitro (Kneifel, and Kulbe 2000).
2.4.1. Bifidobacteria Utilization of GOS. Bifidobacteria have been selected as
targets for prebiotic gut manipulation due to the potential health benefits that come from
having increased numbers in the gut.

Researchers have spent time examining how

different prebiotic carbohydrates affect Bifidobacteria in vitro in order to gain
understanding of the behavior in the gut. In the digestive tract a majority of simple
carbohydrates that promote Bifidobacteria enumeration are absorbed in the stomach and
small intestines. Selecting GOS as a suitable prebiotic is the result of research showing
that

Bifidobacteria

readily utilize GOS

and other oligosaccharides whereas

Enterobacteria and other harmful organisms do not. Hopkins et al. (1993,1985) and
Minami et al. (1998), show evidence that Streptococcus, Lactobacillus, and Escherichia
readily utilize reducing sugars (glucose, fructose, maltose and lactose) but poorly utilize
non-reducing sugars (GOS, FOS, etc) and Bifidobacteria generally utilize mono to
tetrasaccharides, particularly those containing galactose, without requiring an adaptation
period. They also conclude that as a general rule sugars containing galactose, glucose
and fructose are fully utilized by Bifidobacteria (Minami et al. 1983, 1985; Hopkins et al.
1998). Rabiu et al. provide evidence that species show preference for GOS synthesized
using cells of the same species. Table 2.3 lists the growth rates of selected gut bacteria
on synthesized GOS (Rabiu et al. 2001). Evidence of improved growth of Bifidobacteria
species on GOS made using β-galactosidase from the same organism adds to the rationale
for using whole-celled organisms of indigenous gut bacteria for GOS production.

24
Table 2.3 Growth Rates of Selected Gut Bacteria on GOS. 1) Control – Oligomate 2) B.
bifidum BB-12 oligosacharide 3) B. infantis DSM-20088 oligosaccharide 4) B.
pseudolongum DSM-20099 oligosaccharide 5) B. adolescentis ANB-7 oligosaccharide
6) B. angulatum oligosaccharide (Rabiu et al. 2001).

2.4.2. Carbohydrate Source for Culturing and β-Galactosidase Production. In
the gut Bifidobacteria have been shown to have a preference for oligosaccharides while
other less beneficial bacteria cannot process these sugars. Since the hydrolysis from the
enzymes in the Bifidobacteria is desired for GOS production it is convenient to culture
these bacteria. A media that will support the growth of the Bifidobacteria and allow them
to produce the desired enzyme activity level is necessary. Bifidobacteria can grow on a
variety of carbohydrate substrates; preference for a particular substrate is strain
dependent (Hopkins et al. 1998; Mlobeli 1998).

Glucose lends itself as a simple

carbohydrate that allows high cell yields for most strains of Bifidobacteria however
glucose does not induce the expression of the α – galactosidase and β – galactosidase
enzymes which are needed for GOS production or utilization in the gut. Studies showed
that sucrose and fructose are carbohydrates that promote high cell yields but also do not
initiate production of the desired enzymes.

Galactose, lactose and arabinose each

produced some measure of enzyme activity. For Bifidobacterium bifidum, culture media
containing lactose yields the highest growth rate with the highest specific enzyme activity
(Astapovich and Ryabaya 2006). Figure 2.13 is a graph of the β – galactosidase and cell
growth of two strains of B. bifidum cultured on media containing various carbohydrates
as the carbon source.
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Figure 2.13 β–Galactosidase Activity (Dark Columns, U/ml) and Growth (Non Shaded
Columns, mg/ml) of Bifidobacteria on Media with Various Carbon Sources. 1) Sucrose
2) Lactose 3) Galactose 4) Glucose 5) Fructose 6) Maltose 7) Arabinose, 8) Cellobiose
(Astapovich and Ryabaya 2006).

Among the tested carbon sources that demonstrate production of β – galactosidase
during cell culturing, lactose is the highest yielding sugar.

Figure 2.14 is a graph

demonstrating the differences between lactose, glucose and galactose as carbohydrate
sources as measured by cell growth and enzyme activity. As can be seen in the graph the
three sugars perform comparatively in terms of cell growth but lactose yields the highest
enzyme activity (Hsu et al. 2005). Since Bifidobacteria can grow on a lactose substrate,
whey provides a convenient feed stream for culturing species, such as Bifidobacterium
bifidum, as a GOS producing organism.
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Figure 2.14 Effect of Carbon Source on Growth and β – Galactosidase Production (Hsu
et al. 2005).

2.4.3. Nitrogen Source for Culturing and β-Galactosidase Production. With
a vast variety of species and differences between strains even within the same species of
Bifidobacteria specific growth requirements for each has not been thoroughly
investigated; however, much work has been done to find media that supports growth for
all types.

Early investigations focused on developing a defined media capable of

selectively culturing Bifidobacteria species. First attempts at developing a synthetic
medium included a carbohydrate, usually glucose or lactose or both, an assortment of
vitamins, salts, amino acids and a nitrogen source generally called “bifid factors”. Based
on the “bifid factor” chosen different levels of growth activity were observed. Initial
media contained peptone which was later substituted by cow’s milk and then later human
milk (Bezkorovainy and Miller-Catchpole 1989).

Modern media are comprised of

combinations of tryptone, peptone, meat extract, yeast extract, ammonia salts, potassium
salts, magnesium salts, calcium salts, cysteine and Tween 80®.
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The observation of increased activity with the addition of cow and human milk to
the culture media led to further characterization of the growth promoting factors in the
milk as well as investigation into other growth promoting agents. Closer study of both
types of milk revealed that there is a complex mix of protein and non-protein growth
factors (Petschow and Talbott 1991). When separated into casein and whey there is a
significantly greater amount of growth activity associated with casein fractions than whey
fractions for both human and cow milk (Petschow and Talbott 1990). Other growth
promoters were studied as well including yeast extract, gelatin, tryptone, peptone, hog
gastric mucin, bovine serum albumin digest and beef extract (Poch and Bezkorovainy
1988, 1991, Hsu et al. 2005). Research indicates that for strains of Bifidobacteria
bifidum employing yeast extract as the nitrogen growth-promoting source yields the
greatest level of activity (Poch and Bezkorovainy 1988). When yeast extract is used in
conjunction with casamino acids or ascorbic acid in a whey stream, culture cell mass is
almost 100-fold greater than with yeast extract and whey alone and is comparable to
MRS medium (Difco, Detroit MI, USA) which is one of a few complex prepared media
used for culture maintenance (Corre et al. 1992).
While the nitrogen source has a significant impact on the growth kinetics of the
organisms it also appears to impact the β – galactosidase synthesis by the cells. Figure
2.15 shows the effect of nitrogen source on growth and β – galactosidase activity using B.
longum. The growth achieved by each of the nitrogen sources is comparable however
yeast extract as the nitrogen source generates the greatest level of β – galactosidase
activity. Table 2.4 shows the effect of yeast extract concentration on growth and β –
galactosidase production (Hsu et al. 2005).
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Figure 2.15 Effect of Nitrogen Source on the Growth and β–Galactosidase Production by
B. longum CCRC 15708. Medium Contained 4% lactose, 0.3% K2HPO4, 0.1% KH2PO4,
0.05% MgSO4d 7H2O, 0.03% l-Cysteine and Various Nitrogen Sources. Determinations
Were Made After a 12-h Cultivation at 37 °C (Hsu et al. 2005).

Table 2.4 Effect of Yeast Extract Concentration on the Growth and β – Galactosidase
Production by B. longum CCRC 15708. Fermentation Was Conducted in a Medium
Containing 4% Lactose, 0.3% K2HPO4, 0.1% KH2PO4, 0.05% MgSO4d 7H2O, 0.03%
l-Cysteine and Different Concentrations of Yeast Extract at 37 °C for 12 h (Hsu et al.
2005).
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2.4.4. Temperature and pH Effect on Growth and β-Galactosidase Production.
Temperature and pH are important environmental factors to optimize when culturing any
micro-organism. Some organisms are tolerant of a wide range of both temperature and
pH while other organisms require a more controlled environment in order to grow.
Bifidobacteria are organisms which will grow in a range of pHs and at various
temperatures.

Hsu, et al. use B. longum to demonstrate the versatility of the

Bifidobacteria species over a range of pHs and temperatures. Their work also shows the
effect that changes in initial media pH and culture temperatures has on β – galactosidase
activity. Figure 2.16 shows growth and β – galactosidase of B. longum cultures with
varying initial pHs and Figure 2.17 shows growth and β – galactosidase of B. longum
cultures with varying growth temperatures.

Figure 2.16 Effect of Initial pH on the Growth and β–Galactosidase Production by B.
longum. Determinations Were Made After a 12-h Cultivation at 37 °C (Hsu et al. 2005).
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Figure 2.17 Effect of Temperature on the Growth and β–Galactosidase Production by B.
longum. Medium With an Initial pH 6.5 for 12-h Cultivation (Hsu et al. 2005).

As is demonstrated there is not a single factor that determines growth and β –
galactosidase activity of a Bifidobacteria culture. Even within the same species the
enzyme and growth kinetics differ from strain to strain so that carbohydrate source,
nitrogen source with growth factors, pH and temperature should all be investigated in
order to optimize cell growth and β – galactosidase production.
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3. MATERIALS AND METHODS

3.1. REAGENTS AND CHEMICALS
2-Nitrophenyl

β–D-galactopyranoside

(ONPG),

2-nitrophenyl

(ONP),

4-

nitrophenyl α-D-galactopyranoside (PNPG), and 4-nitrophenyl (PNP) were purchased
from Sigma (St. Louis, MO). β –Galactosidase was purchased from Sigma (St. Louis,
MO).

α-Galactosidase was purchased from Deerland

Enzymes (Kennesaw, GA).

Bifidobacteria bifidum NCIMB41171 was provided by Milk Specialties Global
(Carpentersville, IL).

Bifidobacteria bifidum 700541 was purchased from American

Type Culture Company (ATCC, Manassas, VA). DifcoTM dehydrated media components
were purchased from Becton, Dickinson and Company (BD Diagnostics, Franklin Lakes,
NJ).

All other chemicals were purchased from Sigma (St. Louis, MO) or Fisher

Scientific (Fair Lawn, NJ).

3.2. DETERMINATION OF ENZYME ACTIVITY
Reagent Preparation
Stock solution of 100mM sodium phosphate buffer pH 6.8 (phosphate buffer) was
prepared by dissolving the following in deionized (DI) water to make one liter. The
solution was filtered through a 0.2μm filter to remove dust and microbial contaminants.
The resulting buffer is pH 6.8±0.2
8.725 grams Na2HPO4●2H2O (MW 177.99 grams/mole)
7.038 grams NaH2PO4●H2O (MW 137.99 grams/mole)

Stock solution of 120mM sodium tetraborate stop reagent was prepared by
dissolving 45.76 grams Na2B4O7●10H2O (MW 381.37 grams/mole) in one liter DI water
then filtering the solution through a 0.2μm filter to remove dust and microbial
contaminants. Both reagents are stored at room temperature.
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3.2.1. β – Galactosidase Endpoint Assay. A colorimetric assay is used to
determine the enzymatic rate which β – Galactosidase cleaves the glycosidic bond of
ONPG leaving free galactose and ONP. In dilute concentrations, ONP is yellow in color
and is detected by a spectrophotometer at 415nm (A415). An increase in color intensity
indicates hydrolysis. The assay is carried out in 100mM sodium phosphate buffer pH 6.8
at 40°C and stopped using 120mM sodium tetraborate solution.
A.

Standard Curve Preparation
1. Standard solution of 10mM ONP was prepared using volumetric glassware by
dissolving 139 milligrams of ONP (MW 139.1 grams/mole) in enough
phosphate buffer to make 100 milliliters (mL).
2. Standard solution of 1mM ONP was prepared by adding five mL of 10mM
ONP to 45mL phosphate buffer.
3. Standards for measurement were prepared by serial dilution of 1mM ONP
standard in phosphate buffer to 1.35mL of the desired concentration according
to Table 3.1. Each standard was prepared in triplicate.
4. To mimic assay conditions, 0.15 mL phosphate buffer and 3 mL sodium
tetraborate stop reagent were added to each standard. The zero standard was
used to blank the spectrophotometer and the absorbance of each standard was
measured at 415nm using 1cm quartz cuvettes. Figure 3.1 shows the standard
curve with trend line analysis for ONP. Raw data is given in Appendix A,
Table A.1.
The data was analyzed using ANOVA statistics and linear regression. Statistical

results are presented in Table 3.2 and Appendix B. A P-value of <0.0001 indicates that
the linear model for ONP concentration is significant. The standard error can be used as
the standard deviation as indicated by the R Square value.
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Table 3.1 Serial Dilutions of ONP Standard Solutions for Standard Curve.
Volume ONP solution
Volume phosphate
[ONP] mM
(mL)
buffer (mL)
1
1.350
0
0.9
1.215
0.135
0.8
1.080
0.270
0.7
0.945
0.405
0.6
0.810
0.540
0.5
0.675
0.675
0.4
0.540
0.810
0.3
0.405
0.945
0.2
0.270
1.080
0.1
0.135
1.215
Zero standard
0
1.35

Figure 3.1 ONP Standard Curve for β – Galactosidase Assay.
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Table 3.2 ANOVA Statistical Analysis and Regression Output for ONP Standard Curve.
Degrees of
Sum of
Freedom
Squares
Mean Squares F-Value
P-value
Model
1
18.95929753
18.95929753 157408.5
<0.0001
Residual
29
0.003492948
0.000120446
Total
30
18.96279048

Absorbance 415

Coefficients
1.281209437

Standard
Error
0.003229283

Lower 95%
1.274604812

Upper 95%
1.287814062

Regression Statistics
Multiple R
0.999907896
R Square
0.9998158
Standard Error
0.010974812

The extinction coefficient ( ) for ONP was calculated from the standard curve
regression using Equation (1) where A415 is the absorbance measurement, is the slope of
the linear regression divided by dilution factor (ONP volume (mL)/total assay volume
(mL)), and l is the path length (1cm). The experimentally determined value of the
extinction coefficient for ONP is 4.27 mM-1cm-1. The published literature value of the
extinction coefficient for ONP is 4.5 mM-1cm-1 lies outside the 95% confidence interval.
The experimentally determined coefficient was used for the rate calculations.

A415 = [ONP] l

B.

(1)

Enzyme Activity Determination
1.

Stock substrate solution of 10mM ONPG was prepared by dissolving 301.3
milligrams of ONPG (MW 301.3 grams/mole) in 100mL of phosphate buffer.
Buffer was stored cold in a light protective container.

2.

Cell samples were prepared at 1mg/mL dry cell weight in phosphate buffer.
Samples were prepared in duplicate or triplicate depending on the availability
of sample.
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3.

1.35 mL of 10mM ONPG was dispensed into clean glass tubes and
equilibrated to 40°C in a circulating water bath.

4.

0.15 mL of 1 mg/mL cell sample was dispensed into the glass tubes to
initiate the reaction. The reaction was carried out at 40°C for 10 – 20
minutes.

5.

After the appropriate amount of time had elapsed, 3 mL of sodium
tetraborate was dispensed into each tube. The tubes were removed from the
water bath and the ONP concentration was determined by measuring the
absorbance values at 415nm using the spectrophotometer.

6.

A blank was prepared in the same fashion as the samples except the cell
sample was added after the stop reagent to account for turbidity without the
reaction being carried out.

7.

Enzyme activity was calculated as enzyme units (EU)/gram cells/min using
Equation (2). One EU will hydrolyze 1.0 μmole of ONPG to ONP and
galactose per minute.
EU
g / min

A415(TotalVolume)( DilutionFactor )
(Time)( )( SampleVolume)(100mL / g )

(2)

3.2.2. α – Galactosidase Endpoint Assay. A colorimetric assay is used to
measure the enzymatic rate α – Galactosidase cleaves the glycosidic bond of PNPG
leaving free galactose and PNP. In dilute concentrations, PNP is yellow in color and is
detected by a spectrophotometer at 400nm (A400). Increase in absorbance indicates
hydrolysis. The assay is carried out in 100mM sodium phosphate buffer pH 6.8 at 40°C
and stopped using 120mM sodium tetraborate solution.
A. Standard Curve Preparation
1. Standard solution of 10mM PNP was prepared using volumetric glassware by
dissolving 139 milligrams of PNP (MW 139.1 grams/mole) in enough phosphate
buffer to make 100 milliliters (mL).
2. Standard solution of 1mM PNP was prepared by adding 5 mL of 10mM PNP to
45mL phosphate buffer.
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3. Standards for measurement were prepared by serial dilution of 1mM PNP
standard in phosphate buffer to make 1.35mL of the desired concentration
according to Table 3.3. Each standard was prepared in triplicate.
4. To mimic assay conditions 0.15 mL phosphate buffer and 3 mL sodium
tetraborate stop reagent were added to each standard. The zero standard was used
to blank the spectrophotometer and absorbance was measured at 400nm using
1cm quartz cuvettes. Figure 3.2 shows the standard curve with trend line analysis
for PNP. Raw data is given in Appendix A, Table A.2.
The data was analyzed using ANOVA statistics and linear regression. Statistical
results are presented in Table 3.4 and Appendix B. A P-value of <0.0001 indicates that
the linear model for ONP concentration is significant. The standard error can be used as
the standard deviation as indicated by the R Square value.

Table 3.3 Serial Dilutions of PNP Standard Solutions For Standard Curve.
Volume PNP solution
Volume phosphate buffer
[PNP] mM
(mL)
(mL)
0.5
0.675
0.675
0.4
0.540
0.810
0.3
0.405
0.945
0.2
0.270
1.08
0.1
0.135
1.215
BLANK (zero standard)
0
1.35
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Figure 3.2 PNP Standard Curve for α–Galactosidase Assay.

Table 3.4 ANOVA Statistical and Regression Analysis Output for PNP Standard Curve.
Degrees of Sum
of
Freedom
Squares
Mean Squares F-Value
P-value
Model
1
22.71102
22.71102
48904.85 <0.0001
Residual
11
0.005108
0.000464
Total
12
22.71613

Absorbance 400

Coefficients
5.023392222

Regression Statistics
Multiple R
0.999887556
R Square
0.999775124
Standard Error
0.021549756

Standard
Error
0.022715438

Lower 95%
4.973395881

Upper 95%
5.073388564
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The extinction coefficient ( ) for PNP was calculated from the standard curve
regression using Equation (3) where A400 is the absorbance measurement, is the slope of
the linear regression divided by dilution factor (PNP volume (mL)/total assay volume
(mL)), and l is the path length (1cm). The experimentally determined value of the
extinction coefficient for PNP is 16.74 mM-1cm-1. The published literature value of the
extinction coefficient for PNP is 18.5 mM-1cm-1 is outside the 95% confidence interval so
the experimentally determined value is used for rate calculations.

A400 = [PNP] l

(3)

B. Enzyme Activity Determination
1. Stock substrate solution of 10mM PNPG was prepared by dissolving 301.3
milligrams of PNPG (MW 301.3 grams/mole) in 100mL of phosphate buffer.
Buffer was stored cold in a light protective container.
2. Cell samples were prepared at 1mg/mL dry cell weight in phosphate buffer.
Samples were prepared in duplicate or triplicate depending on the availability of
sample.
3. 1.35 mL of 10mM PNPG was dispensed into clean glass tubes and equilibrated
to 40°C in a circulating water bath.
4. 0.15 mL of 1 mg/mL cell sample was dispensed into the glass tubes to initiate the
reaction. The reaction was carried out at 40°C for 20 – 40 minutes.
5. After the appropriate amount of time had elapsed, 3 mL of sodium tetraborate
was dispensed into each tube. The tubes were removed from the water bath and
the ONP concentration was determined by measuring the absorbance values at
415nm using a spectrophotometer.
6. A blank was prepared in the same fashion as the samples except the cell sample
was added after the stop reagent to account for turbidity without the reaction
being carried out.
7. Enzyme activity was calculated as enzyme units (EU)/gram cells/min using
Equation (4). One EU will hydrolyze 1.0 μmole of PNPG to PNP and galactose
per minute.
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EU
g / min

A400(TotalVolume)( DilutionFactor )
(Time)( )( SampleVolume)(100mL / g )

(4)

3.2.3. β - Galactosidase Kinetic Assay. Using ONPG as a substrate, purified
enzyme activity was determined using the kinetic colorimetric assay adapted from Sigma
Corporation (St. Louis, MO) protocol SPONPG01 “Enzymatic Assay of β Galactosidase”.

Enzyme and substrate solutions were made by adding crystals to

phosphate buffer adjusted to make a known concentration stock solutions.

Stock

solutions were made fresh for each experiment. Test samples were made by serial
dilution of the stock solution to the desired concentration. Cuvette volume was 3mL.
With the exception of data gathered on the effect of temperature on reaction rate, all
experimental runs were controlled at 37°C by a circulating water bath.
A. Reagent Preparation
1. Stock solution of 100mM sodium phosphate buffer pH 7.2 (phosphate buffer) was
prepared by dissolving the following in deionized (DI) water to make one liter
then filtering the solution through a 0.2μm filter to remove dust and microbial
contaminants. The resulting buffer is pH 7.2±0.2
3.338 grams Na2HPO4●2H2O (MW 177.99 grams/mole)
13.146 grams NaH2PO4●H2O (MW 137.99 grams/mole)

2. Stock solution of 30mM magnesium chloride reagent was prepared by dissolving
0.608 grams MgCl2●6H2O (MW 203.31 grams/mole) in 100mL phosphate buffer
pH 7.2. Both reagents are stored at room temperature.
B. Computer Software Interface
The Agilent 8543 diode array spectrophotometer with UV/VIS Chemstation
software version A.09.01 with the Kinetics module Biochem Analysis Software was used
to collect and record data. A method was created using the following conditions:
Wavelength – 415nm
Background Correction – Subtract Average 550-650nm
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Run Time – 600s (run time changed for tests requiring less or more time)
Cycle Time – 20s (how often the detector gathers data from the test cells)
Start Time – 0s (When the detector starts collecting data)
Kinetic Calculation – Initial Rate Calculation
The initial rate calculation is determined from the linear portion of the data curve.
All rate calculations were made using the time point immediately preceding the reaching
or exceeding the limit of detection as the last data in the linear portion of the curve.
Before adding samples to the cuvettes a “zero cells” function was performed to
remove any variations among the quartz cuvettes. The cuvette tray holds up to eight
cells. The software was configured for the number of samples to be run with a blank run
with each test condition.
C. Enzyme Activity Determination
1. Stock substrate solution of 68mM ONPG was prepared by dissolving 0.204 grams
of ONPG (MW 301.3 grams/mole) in 10mL of phosphate buffer. Buffer was
stored cold in a light protective container.
2. Enzyme stock solution was prepared at 2-4 U/mL in phosphate buffer by diluting
a stock solution at 3000 U/mL by 1/1000.
3. Prepare test cuvettes per Table 3.5.

Table 3.5 Sample Preparations for Kinetic Experiments of β –Galactosidase (Analysis
performed by L. Jorgenson, A. Sutterer, and J. Roam).
Substrate Concentration (mM)
Blank

1.13

2.27

4.53

9.07

18.13

Phospate
Buffer

2.70 ml

2.65 ml

2. 60 ml

2.50 ml

2.30 ml

1.90 ml

MgCl2

0.10 ml

0.10 ml

0.10 ml

0.10 ml

0.10 ml

0.10 ml

Enzyme

0.10 ml

0.10 ml

0.10 ml

0.10 ml

0.10 ml

0.10 ml

Substrate

-

0.05 ml

0.10 ml

0.20 ml

0.40 ml

0.80 ml

Inhibitor

0.10 ml

0.10 ml

0.10 ml

0.10 ml

0.10 ml

0.10 ml
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4. Immediately before adding the enzyme solution to the cuvettes, start the data
collection on the software. Add the enzyme solution to each of the cuvettes
before the first data point was collected.
5. Allow the method to run to completion then adjust the calculation range for the
initial rate based on the data.
6. Enzyme activity was calculated as enzyme units (EU)/gram cells/min using
Equation (5). One EU will hydrolyze 1.0 μmole of ONPG to ONP and galactose
per minute.

EU
mL / min

Rate(TotalVolume)( DilutionFactor )
( )( SampleVolume)

(5)

3.2.4. α – Galactosidase Kinetic Assay. Using PNPG as a substrate, purified
enzyme activity was determined using a kinetic colorimetric assay adapted from Bioassay
Systems protocol POPN006 “pNPP Phosphatase Assay”. Enzyme and substrate solutions
were made by adding crystals to phosphate buffer to make a known concentration stock
solutions. Stock solutions were made fresh for each experiment. Test samples were
made by serial dilution of the stock solution to the desired concentration.

Cuvette

volume was 3mL. For each data point a blank was made consisting of 1.5mL of the
PNPG solution and 1.5mL of phosphate buffer in place of enzyme solution. With the
exception of data gathered on the effect of temperature on reaction rate, all experimental
runs were controlled at 25°C by a circulating water bath.
A. Computer Software Interface
The Agilent 8543 diode array spectrophotometer with UV/VIS Chemstation
software version A.09.01 with the Kinetics module Biochem Analysis Software was used
to collect and record data. A method was created using the following conditions:
Wavelength – 400nm
Background Correction – Subtract Average 550-650nm
Run Time – 1800s (run time changed for tests requiring less or more time)
Cycle Time – 30s (how often the detector gathers data from the test cells)
Start Time – 0s (When the detector starts collecting data)
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Kinetic Calculation – Initial Rate Calculation
The initial rate calculation is determined from the linear portion of the data curve.
All rate calculations were made using the time point immediately preceding the reaching
or exceeding the limit of detection as the last data in the linear portion of the curve.
Before adding samples to the cuvettes a “zero cells” function was performed to
standardize the lamp against any noise that may be introduced by the quartz cuvettes.
The cuvette tray holds up to eight cells. The software was configured for the number of
samples to be run with a blank run with each test conditon.
B. Enzyme Activity Determination
1. Prepare the appropriate dilutions of the enzyme and substrate solutions.
2. Dispense 1.5 mL of the non variable solution into each of the cuvettes (ie if
testing changing enzyme concentrations then substrate concentration is the non
variable). When testing temperature effects add either substrate or enzyme but do
not mix the solutions until ready to begin measurements.
3. Immediately before adding the variable solution to the cuvettes start the data
collection on the software. Add 1.5 mL of the variable solution to each of the
cuvettes before the first data point is collected.
4. Allow the method to run to completion then adjust the calculation range for the
initial rate, based on the data. A typical data plot is shown in Figure 3.3.
5. Enzyme activity was calculated as enzyme units (EU)/mg enzyme/min using
Equation (6). One EU will hydrolyze 1.0 μmole of PNPG to PNP and galactose
per minute.

EU
mg / min

Rate(TotalVolume)( DilutionFactor )
( )( SampleVolume)( EnzymeConcentration)

(6)
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Figure 3.3 Example of a Typical Kinetic Assay Data Plot Used for Initial Rate
Determination.

3.3. DRY-CELL WEIGHT DETERMINATION
Cell growth was determined by measuring the turbidity of the culture broth with
time. The optical density (OD) probe was a Fundalux II detecting at wavelength 910nm
used in conjunction with a Biostat® B Plus two-liter bioreactor with a 1.5 liter working
volume. Micro DCU system software was used to control the bioreactor and record time
point data of the cultures. An increase in turbidity indicated an increase in the number of
cells present in the reactor. A set of standards were made using Bifidobacteria bifidum
NCIMB41171. A 10 gram/liter cell slurry was made by weighing out three grams of
freeze dried cells and mixing with 300 milliliters sodium phosphate buffer. The cell
slurry was allowed to stir for 30 minutes to ensure a homogenous mixture.

Serial

dilutions of the 10 gram/liter solution were made as shown in Table 3.6 for the standard
curve. A total of 20mL was needed for each measurement. All standards were made in
triplicate. Raw data is given in Appendix A, Table A.3.

44

Table 3.6 Serial Dilutions of 10g/L NCIMB41171 Cell Slurry.
Volume phosphate buffer
Cell Density (g/L)
Volume Cell Slurry (mL)
(mL)
7.5
15
5
5
10
10
4
8
12
3
6
14
2.5
5
15
2
4
16
1.5
3
17
1
2
18
0.5
1
19
0.25
0.5
19.5
0.1
0.2
19.8
Blank
0
20

The data follows a nearly exponential curve in the form shown in equation 7
however this model does not hold true at cell densities below 1gram/liter. Cell densities
at or below 1 gram/liter are analyzed using linear regression (8) while cell densities
greater than 1 gram per liter are analyzed using the exponential fit (7) where C and M are
constants found through regression and OD is the optical density. Figure 3.4 shows the
standard curve used for determining dry cell weight.

Cell Density > 1 gram/liter:

Cell Density ≤ 1 gram/liter:

e

OD910

= C M *Cell Density

OD910 = C + M*Cell Density

(7)

(8)
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Figure 3.4 Dry Cell Weight Standard Curve. Linear Fit (Turbidity = 0.037635 +
0.7546631*Cell Density); Exponential Fit (Exp(OD910) = 0.4622332 + 1.7887159*Cell
Density).

The data was analyzed using ANOVA statistics and linear and nonlinear
regression. Statistical results are presented in Table 3.7, Table 3.8 and Appendix B. A Pvalue of <0.0001 indicates that the models for cell density are significant. The standard
error can be used as the standard deviation as indicated by the R Square value.

Table 3.7 ANOVA Statistical Analysis Output for Dry Cell Weight Standard Curve
(Linear).
Degrees of
Freedom

Sum
Squares

Mean Squares

F-Value

P-value

Model

1

2.5858120

2.58581

2847.803

<.0001

Residual

11

0.0099880

0.00091

Total

12

2.5958000

Regression Statistics
R Square
0.999004
Standard Error
0.114113

of
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Table 3.8 ANOVA Statistical Analysis Output for Dry Cell Weight Standard Curve
(Exponential).
Degrees of
Freedom

Sum
Squares

of
Mean Squares

F-Value

P-value

Model

1

248.19015

248.190

19059.70

<.0001

Residual

19

0.24741

0.013

Total

20

248.43756

Regression Statistics
R Square
0.995026
Standard Error
0.019969

3.4. SUGAR ANALYSIS BY HPLC
Sugars were analyzed using a Phenomenex Rezex-RCM ion exchange column in
calcium form on an Agilent HP 1090 high performance liquid chromatograph (HPLC)
using Chemstation A.03 software. The mobile phase was Milli-Q® water (18 mega-ohm
resistivity) at 0.6 mL/min flow rate. The column temperature was controlled at 850C. The
detector was an Agilent 1037 refractive index detector operated at 400C. The injection
size was 10 µL for all samples and each sample is injected in duplicate. The Chemstation
software calculates the area under the curve and generates calculated concentrations for
each mixuture.
Standard Curve Preparation
Standard solutions A and B were prepared per Table 3.9 by O. Sitton. Standard A
is a mixture of four oligosaccharides: maltohexaose (DP6), maltopentaose (DP5),
maltotetraose (DP4) and maltotriose (DP3). Standard B is a mixture of lactose, glucose,
and galactose. Injection samples are 500 microliter volumes made up of differing ratios
of A and B with known concentrations of each sugar.

Figure 3.5 is an example

chromatograph showing typical retention times for each sugar.

The known

concentrations are the expected values which the HPLC results are being compared to for
accuracy. Table 3.10 shows the mixture ratios and the expected sugar concentration for
each sample.
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Table 3.9 Standard Solution Sugar Concentration.
Sugar Concentration (gram/Liter)
Standard

DP6

DP5

DP4

DP3

Lac

Glc

Gal

A

9.91

9.45

9.82

20.4

-

-

-

B

-

-

-

-

102.08

51.33

52.96

30.174

26.078

ADC1 A, ADC1 CHANNEL A (C090721\002-0302.D)
mV
65

60

34.656

40

36.393

45

21.427

19.766

50

23.507

55

35

15.999
16.665
17.497
18.536

30

25

5

Sugar
DP6
DP5
DP4
DP3
Lactose
Glucose
Galactose

10

15

20

25

30

35

Retention Time(min)
19.766
21.427
23.507
26.078
30.174
34.656
36.393

Figure 3.5 Sample HPLC Chromatagraph with Rention Time for Each Sugar.

min
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Table 3.10 Expected Sugar Concentrations for Samples.
Expected Sugar Concentration (gram/Liter)
Mixture
Ratio %
DP6
DP5
DP4
DP3
Lac
Glc
(A:B)
9.91
9.45
9.82
20.4
100:0
8.92
8.51
8.84
18.36
10.21
5.13
90:10
7.93
7.56
7.86
16.32
20.42
10.27
80:20
6.94
6.62
6.87
14.28
30.62
15.40
70:30
5.95
5.67
5.89
12.24
40.83
20.53
60:40
4.96
4.73
4.91
10.2
51.04
25.67
50:50
3.96
3.78
3.93
8.16
61.25
30.80
40:60
2.97
2.84
2.95
6.12
71.46
35.93
30:70
1.98
1.89
1.96
4.08
81.67
41.06
20:80
0.99
0.95
0.98
2.04
91.87
46.20
10:90
102.08
51.33
0:100

Gal
5.30
10.59
15.89
21.18
26.48
31.78
37.07
42.37
47.66
52.96

The data was analyzed using ANOVA statistical analysis. Lactose is determined
using a quadratic fit. Glucose and galactose are determined using a linear fit. Figure 3.6
shows the standard curves and their statistical results are presented in Table 3.11. A Pvalue of <0.0001 indicates that the models for concentration is significant. The standard
error can be used as the standard deviation as indicated by the R Square value. These
results are found in Appendix B.
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Figure 3.6 Standard Curves with Equations of Fit for Glucose, Galactose and Lactose.

Table 3.11 ANOVA Statistical Analysis Output for Galactose, Glucose and Lactose.
Degrees of
Sum of
Freedom
Squares
Mean Squares F-Value
P-value
Lactose
Model
2
221148151
110574076
6886.007 <.0001
Residual
27
433560
16057.793
Total
29
221581712
Glucose
Model
1
82665096
82665096
36767.46
<.0001
Residual
28
62953
2248.3221
Total
29
82728049
Galactose
Model
1
83899719
83899719
33356.97
<.0001
Residual
28
70426
2515.2082
Total
29
83970145

R Square
Standard Error

Regression Statistics
Glucose
Lactose
0.998043
0.999239
126.719
47.416

Galactose
0.999161
50.152
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3.5. MEDIA PREPARATION FOR ANAEROBIC CELL CULTURE
Bifidobacteria require an anaerobic growth environment. Media was prepared as
follows for culture tubes and vials.
1. Dissolve media components in Milli-Q® water so that the flask contains not more
than 75% of the maximum flask volume. Mix by magnetic stirring. For media with
high sugar concentration prepare the sugar and nitrogen components separately at
appropriate concentrations such that they are the correct concentrations when mixed
for the final media.
2. Stop stirring and allow the liquid to come to rest. Mark the liquid edge on the
outside of the flask. Add 10-20mL additional water to account for liquid that will be
lost during the oxygen purging process.
3. If necessary add methylene blue as an oxygen indicator at 5 milligrams/liter.
4. Turn on the Thermalene® 2110 Tube Furnace and set the temperature to 260°C.
Allow the furnace to come to temperature.
5. Strip the furnace of oxygen by flowing “forming” gas (90:10, N2: H2) through the
heater for 10 minutes. Stop flowing “forming” gas.
6. Purge “forming” gas from the heater by flowing “purge” gas (80:20, N2: CO2). This
gas is used to purge the oxygen from the media and fill the headspace in the flask.
7. Gently heat the media while stirring slowly using magnetic stirring. If methylene
blue is present in the media a lack of blue color indicates oxygen free media.
8. Place a rubber stopper with holes for gas delivery and venting in the flask opening as
in Figure 3.7. Ensure the tip of the gas delivery tube is just above the liquid level
and the end of the vent tube is as close to the bottom of the rubber stopper as
possible to allow for efficient gas exchange.
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Figure 3.7 Oxygen Purge Setup for Anaerobic Media Preparation.
9. Continue heating and gently stirring the flask allowing the liquid to come to a low
boil. Stirring is not necessary however if a stir bar is present it will act as a boiling
stone in the bottom of the flask.
10. Direct the purge gas to the gas delivery tube and purge the oxygen from the media
and the flask head space for a minimum of 15-20 minutes. Continue to heat the
system with gas flow until the volume in the flask reaches the mark made in step 2.
11. Remove the deoxygenated media from the heat source. While the media is still hot
exchange the rubber stopper for a solid stopper and seal the container airtight.
12. Transfer the flask to the anaerobic chamber and allow the liquid to cool.
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13. Dispense the cooled anaerobic media into clean vials and culture tubes which have
been equilibrated in the anaerobic chamber for a minimum of 24 hours. Cap tubes
and vials airtight.
a. For media with high sugar concentration and nitrogen components prepared
separately, keep the solutions separate and seal the containers airtight for
autoclaving.
b. Prepare clean empty vials and tubes, sealed airtight for autoclaving, for media
preparation after sterilizing the components separately.
14. Sterilize the prepared containers and media in an autoclave for 15-20 minutes at
121°C.
15. Remove the sterile media and containers from the autoclave while still hot. Transfer
the containers and media to the anaerobic chamber and allow to cool completely.
a. Mix media components in the prepared containers to the correct concentrations
while still warm to the touch but not hot.
16. Label the tubes and vials with the contents and store at room temperature until ready
to use.

Media was prepared as follows for the two-liter bioreactor.
1. Dissolve the media components in Milli-Q® water keeping the carbohydrates
separate from the nitrogen components. Divide the volume into halves and make
each half 2X concentration. Final volume for most cultures is one liter.
2. If necessary add methylene blue as an oxygen indicator at 5 milligrams/liter.
3. Prepare a 250 milliliter bottle of 1N sodium hydroxide (NaOH).
4. Prepare a 250 milliliter bottle of antifoam solution.
5. Standardize the reactor inline pH probe with pH buffers 4.01 and 7.00.
6. Ensure the reactor is clean then add either the prepared nitrogen based solution or the
prepared carbohydrate based solution to the reactor vessel.
7. Put the lid on the reactor and loosely fasten the bolts to hold down the lid.
8. Close or clamp all the ports on the reactor.
9. Put in place the pH probe, the turbidity probe, the antifoam sensors, the oxygen
sensor and the septum.

53
10. Sterilize the reactor, remaining media component, sodium hydroxide solution and
antifoam in an autoclave for 30 minutes at 121°C.
11. Remove reactor and other components from the autoclave.
12. Connect the antifoam and sodium hydroxide solution through the Biostat Bplus
pump to the reactor feed ports.
13. Tighten down the reactor lid and unclamp the necessary ports for venting and feed
solutions.
14. Attach all ancillary components of the reactor.
a. Attach the water jacket hoses and begin cooling the reactor to 50°C.
b. Attach the agitator motor and turn on at 100rpm to assist in the cooling of
the reactor contents.
c. Attach gas tubes to gas inlet ports and unclamp ports.
d. Attach off-gas condenser.
e. Attach all sensor cables.
15. As aseptically as possible, transfer the remaining media component to the reactor
through one of the addition ports.
16. Allow “beer gas” (75:25, N2:CO2) flow at low flow to purge oxygen from the media
and create a N2/CO2 blanket in the headspace of the reactor. Purge for a minimum
of one hour.
17. Adjust the control temperature of the reactor to 37°C.
18. Using the pump on the Biostat B Plus gradually add sodium hydroxide solution to
reach the desired pH.
19. Allow the reactor to stir at 37°C overnight to verify sterility and ensure the media is
anaerobic.
20. Zero the optical density probe.

3.6. ANAEROBIC CELL CULTURE
Cells were cultured anaerobically at 37°C for a minimum of 12 hours. Cells
cultured in tubes or vials were gently stirred using an incubating shaker or mixed
periodically by hand to minimize the effects of nutritional micro environments. Cells
cultured in the Biostat® B plus were mixed using the unit agitator at 150 Rpm and
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sparged with beer gas (75:25, N2:CO2) to keep the culture oxygen free and the reactor
under positive pressure. Cultures were inoculated with 1% total volume using cultures in
exponential growth phase. To verify aseptic technique for vial and tube preparations a
blank tube was inoculated with sterile media and incubated under the same conditions.
For cultures in tubes and vials pH was not controlled however final pH was
recorded. In the bioreactor pH was measured, recorded and in some cases controlled
during the culture lifecycle. Cultures were stored at 4°C to serve as future inoculum or
for additional testing.
3.7. CELL CULTURE CONDITIONS
In order to understand how changes in culture media influenced cell growth, B.
bifidum ATCC 700541 was cultured on enhanced reinforced clostridial medium (RCM)
as a reference media. A cell bank was started from a single ampule of freeze dried cells
and anaerobically cultured using RCM with no additional components through two
inoculation cycles before being used to seed batch cultures for evaluation. Table 3.12
lists the formula for the enhanced RCM. For comparison batch cultures in the Biostat ® B
Plus were cultured with and without pH control. Batches that were controlled were held
at pH 6.5 – 6.8 using 1N sodium hydroxide.
Since B. bifidum readily utilizes glucose as a carbohydrate source, cells were
grown on the reference media with increased glucose concentrations in attempt to find a
cell density limit for the culture.
One of the challenges to using Bifidobacteria cells for the GOS transformation
reaction is they are a species that is especially difficult to grow on a purely synthetic
medium. The desire to culture the organisms on synthetic media is purely economic.
The more components a medium has the more expensive it is to use. Two synthetic
media modified from the Norris Medium were chosen in attempts to culture B. bifidum
ATCC 700541 using minimal medium components.

The formulas for each of the

selected media can be found in Table 3.13, Table 3.14, and Table 3.15. Since the
minimal media did not contain any glucose, complex amino acids or vitamins the cultures
needed to be gradually introduced to the medium by stepping down from the RCM by a
series of dilutions as listed in Table 3.16.
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Table 3.12 Difco™ Reinforced Clostridial Medium (RCM).
Approximate Formula
Media Component
Grams Per Liter
Pancreatic Digest of Casein

5.0

Proteose Peptone No. 3

5.0

Beef Extract

10.0

Yeast Extract

3.0

Dextrose (glucose)

5.0

Sodium Chloride

5.0

Soluble Starch

1.0

Cysteine Hydrochloride

0.5

Sodium Acetate

3.0

Agar

0.5
Components Added (Enhanced RCM)

Potassium phosphate, dibasic

4.5

Sodium phosphate, dibasic

6.0

Table 3.13 Minimal Media (Bezkorovainy and Miller-Catchpole 1989).
Approximate Formula
Media Component
Grams Per Liter
Ammonium Acetate
4
Sodium Acetate

50

Potassium phosphate, dibasic

5

Cysteine

0.4

Lactose

70

Biotin

0.008 mg

Calcium Pantothenate

0.8 mg

Salts “B” Solution

10mL
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Table 3.14 Modified Minimal Media (Bezkorovainy and Miller-Catchpole 1989).
Approximate Formula
Media Component
Grams Per Liter
Ammonium Acetate

4

Potassium phosphate, dibasic

5

Lactose

70

Cysteine

0.4

Tween® 80

2

Calcium Pantothenate

0.8 mg

Biotin

0.008 mg

Ascorbic Acid

0.02

Salts “B” Solution

10mL

Table 3.15 Salts B Solution (Bezkorovainy and Miller-Catchpole 1989).
Approximate Formula
Media Component
Grams Per 250 mL
Magnesium Sulphate Heptahydrate

10

Iron Sulphate Heptahydrate

0.5

Sodium Chloride

0.5

Manganese Sulphate Dihydrate

0.337

Table 3.16 Dilutions for Media Adaptation to Minimal Media.
Volume Complex
Volume Minimal Media
Media Ratio
Media (mL)
(mL)
100:0

15

0

67:33

10

5

33:67

5

10

0:100

0

15
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Cell growth was determined by a drop in pH from the starting media after a 24
hour incubation. The results were compared to growth in the RCM. Table 3.17 is a
summary of the cell adaptation. The two media conditions chosen were termed “minimal
media” and “modified minimal media” and their formula can be found in Appendix C.

Table 3.17 Cell Adaptation Summary Table.
Media
Starting pH

Ending pH

RCM

6.61

4.46

1/3 Minimal Media, 2/3 RCM

6.80

4.60

2/3 Minimal Media, 1/3 RCM

6.91

4.85

Minimal Media

6.99

6.79

1/3 Modified Minimal Media,
2/3 RCM
2/3 Modified Minimal Media,
1/3 RCM
Modified Minimal Media

6.83

7.05
7.21

4.21

4.21

6.91
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4. RESULTS

4.1. CELL GROWTH ON REFERENCE MEDIA
In order to understand how changes in culture media influenced cell growth B.
bifidum ATCC 700541 was cultured on enhanced reinforced clostridial medium (RCM)
as a reference media. For comparison batch cultures in the Biostat® B Plus were cultured
with and without pH control. Batches that were controlled were held at pH 6.5 – 6.8
using 1N sodium hydroxide. Figure 4.1 shows the growth profile of the biostat culture
without pH control.

6.9
6.7

1.9

6.5
1.4

6.3

0.9

6.1

pH

Dry Cell Weight (g/L)

2.4

5.9
0.4

5.7

-0.1

5.5
0

5

10

15

20

Time (hrs)
Cell Density

pH

Figure 4.1 Time-Course of Cell Growth in Reference Medium Without pH Control.

B. bifidum readily cells were also grown on the reference media with increased
glucose concentrations in attempt to find a cell density limit for the culture. Results are
shown in Figure 4.2 and summarized in Table 4.1.
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Figure 4.2 Time-Course Plot of Cell Growth in Reference Medium for Increasing
Glucose Concentrations. Reference Media is 10 g/L Glucose. Batches are not pH
Controlled.

Table 4.1 Reference Media Cell Culture Data Summary.
Glucose Concentration in
Media (g/L)

Maximum Cell
Density (g/L)

10

2.0

Remaining Glucose
Concentration by
HPLC (g/L)
0

30

4.1

20

50

4.6

30

From this plot it can be seen that increasing glucose allows the culture to reach a
greater cell density than in the reference culture. As can be expected the cells grown in
media containing 50 g/L glucose have a higher growth rate during the exponential phase
and they remain in lag phase for a greater amount of time but they reach a greater cell
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density overall. Both the 30 g/L and 50 g/L glucose seem to move into stationary phase
at approximately the same time indicating that there is either the depletion of a nutritional
component limiting further growth or there is an accumulation of a metabolite which
inhibits growth. HPLC analysis of broth samples from the end of each fermentation
show an excess of glucose remaining in the medium. A comparison plot of a pH
controlled fermentation and non controlled fermentation is shown in Figure 4.3. During
the pH controlled run there was a disruption of base addition however once the system is
brought back under control it recovers and continues to increase in cell density. Figure
4.3 also shows the pH of each batch over time.

Figure 4.3 Comparison of a pH Controlled Batch Fermentation with a non pH Controlled
Batch Fermentation with Overlay of the pH of Each Batch.
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4.2. CELL GROWTH ON TEST MEDIA
One of the challenges to using Bifidobacteria cells for the GOS transformation
reaction is they are a species that is especially difficult to grow on a purely synthetic
medium. As expected the cells did not readily grow on the purely synthetic media. For
both the minimal media and the modified minimal media the drop in pH could possibly
be attributed to the effect of the low pH inoculum however, the modified minimal media
which was originally formulated to grow cells in suspension and on solid media did have
some turbidity after the incubation period
After adapting the cells to the minimal media an attempt to grow the cells on the
two media was made over a 6 day incubation period. The time progression data is shown
in Table 4.2.

Table 4.2 Synthetic Media Growth Study Results.
Media
Day
pH
Minimal Media RCM

Modified Minimal
Media

Cell Density (g/L)

0

7.04

-

1

6.94

-

2

6.93

-

3

6.94

-

4

6.85

-

5

6.85

-

6

6.85

0.005

0

7.31

-

1

6.95

-

2

6.91

-

3

6.52

0.005

4

6.16

0.017

5

5.57

0.124

6

5.48

0.389
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The results of this trial show that this strain of Bifidobacteria requires media
enhancements such as the bifid factors of yeast extract in order to be able to grow for
GOS production.
Bifidobacteria bifidum NCIMB41171 has been successfully cultured using a
medium containing yeast extract, meat extract and tryptone. The media used by Goulas
et al. were selected as media for enumeration and enzyme production. The media are
termed “propagation medium” and “enzyme medium” and their formula can be found in
Table 4.3. Cells were adapted to the media by culturing them in enhanced RCM with 10
grams per liter lactose added to the media. A cell bank was started by culturing the cells
through two inoculation cycles on propagation medium before being used to seed batch
cultures for evaluation. The cells were cultured in a similar fashion as with the reference
media. The growth curves for each media are presented in Figure 4.4.

Table 4.3 B. bifidum media. Approximate Formula Grams Per Liter (Tzortis et al. 2005).
Media Component
Propagation
Enzyme
Tryptone

15

7.5

Meat Extract

2.5

7.5

Yeast Extract

7.5

7.5

Potassium phosphate, dibasic

4.5

2

Cysteine Hydrochloride

0.05

0.5

Lactose

2.5

4

Glucose

7.5

6

1 mL

0.5 mL

Tween™ 80
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Figure 4.4 Time-Course of Cell Growth in Propagation and Enzyme Media. Reference
Media is 10 g/L Glucose. Batches are pH Controlled.

From this plot it can be seen that this strain of Bifidobacteria responds very well
to the bifid factors in the media with the same sugar concentration as in the reference
medium. The cells grown in propagation medium reach a maximum cell density of 6.5
grams per liter and the cells grown in enzyme cell medium reach a level of 4.8 grams per
liter. Both media outperform the RCM at all glucose concentrations.
Using the propagation medium, a study was performed to look at varying the
concentration of lactose for growth and how it affected cell growth and enzyme activity.
The concentrations selected for study were 10g/L, 30 g/L, 50 g/L, 100 g/L and 250 g/L
(1%, 3%, 5%, 10%, and 25%) lactose with glucose concentration constant at 7.5 g/L. For
each lactose concentration a set of eight culture tubes were prepared. The initial pH of
the medium was not adjusted prior to inoculation and the pH of the cultures was not
adjusted during the study. All the tubes were inoculated with 1% inoculum at the same
time from the same base culture and incubated at 37°C for the duration of the trial.
Samples were taken by removing a tube from the incubator and measuring the turbidity
and pH immediately.

Figure 4.5 shows the growth curves of each of the lactose

concentrations. The results for the study are presented in Table 4.4.
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Figure 4.5 Cell growth of B. bifidum ATCC 700541 on Varying Concentrations of
Lactose in Propagation Medium.

Table 4.4 Lactose in Propagation Media Results.
1%
Time
(hrs)
0
8
10
11
12
13
16
18
37

pH
7.08
6.85
6.38
5.54
5.13
4.74
4.56
4.54

Cell
Mass
(g/L)
0.175
0.745
1.261
1.793
2.802
2.991
3.023

3%

pH
6.94
6.39
5.62
5.31
4.77
4.67
4.57
4.48

Cell
Mass
(g/L)
0.586
1.187
1.543
2.682
2.927
3.124
3.124

5%

pH
6.88
5.59
4.75
4.67
4.59
4.51
4.49
4.42

Cell
Mass
(g/L)
1.116
2.624
2.802
2.991
2.802
3.024
3.090

10%
Cell
Mass
pH
(g/L)
6.59
4.99 1.261
4.75 2.009
4.62 2.402
4.5
2.483
4.54 2.511
4.47 2.429
4.41 2.298

25%
Cell
Mass
pH
(g/L)
6.5
6.04 0.096
6.06 0.056
6.05 0.056
5.81 0.096
5.59 0.162
5.42 0.228
5.11 0.401
4.38 1.143

Looking at the data it appears that cells grown on 1%, 3% and 5% reach a
maximum cell density of approximately 3 g/L and a minimum pH of 4.4 – 4.5. The
initial growth rate increases as the lactose concentration increases until the concentration
exceeds 10% then it appears that the cell growth is inhibited by the concentration of sugar
in the medium.
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4.3. CELLULAR BETA GALACTOSIDASE ACTIVITY
In order to determine if Bifidobacteria bifidum ATCC 700541 is an economically
viable option for producing GOS, the amount of β-galactosidase activity by the cells is
determined by an endpoint colorimetric assay.

The cells were separated from the

fermentation broth by centrifugation and resuspended in phosphate buffer at
approximately 1mg/mL cell density. The activity of the cells cultured on propagation
medium was found to be 10.94 EU/gram/min. The activity of the cells cultured on
enzyme medium was found to be 23.61 EU/gram/min. For comparison Bifidobacteria
bifidum NCIMB 41171 cells were tested and found to have activity levels of ~400
EU/gram/min. The time point data from the 1% and 3% samples in the lactose growth
study were tested for β-galactosidase activity. As can be seen in Figure 4.6 in the 1%
samples β-galactosidase activity increases with time whereas in the 3% samples the
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activity remains fairly constant.

18

Time (hrs)
1% Lactose

3% Lactose

1% Beta Gal Activity

3% Beta Gal Activity

Figure 4.6 β-Galactosidase Activity and Cell Density of B. bifidum ATCC 700541
Cultured With 1% and 3% Lactose in Propagation Medium.
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4.4. CELLULAR ALPHA-GALACTOSIDASE ACTIVITY
Bifidobacteria which have α-galactosidase activity make it possible for the cells
to utilize alpha-linked sugars and if the α-galactosidase has transgalactosylation
capabilities the organism can be used to make alpha-linked GOS molecules from lactose.
To determine if B. bifidum ATCC 700541 had α-galactosidase activity the 1% culture
from the lactose growth study was tested using the α-galactosidase endpoint assay.
Figure 4.7. shows the results of the study.
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Figure 4.7 α-Galactosidase Activity of B. bifidum ATCC 700541 Cultured With 1%
Lactose in Propagation Medium.
As was seen with β-galactosidase there is an increase in activity with time. Cells
cultured on enzyme medium expressed similar levels of activity as those cultured on
propagation medium. The α–galactosidase activity of B. bifidum ATCC 700541 was
found as 6.37 EU/gram/min.

67
4.5. UNBOUND ENZYMEACTIVITY
In order to compare the economics of making GOS using Bifidobacteria bifidum a
baseline for comparison is established by determining the rates for the unbound enzymes.
The enzyme activities for both galactosidases were determined experimentally by
reacting a constant enzyme concentration with varying substrate concentrations.
Michaelis–Menten kinetics (9) were used as the model and plotted using an Eadie–
Hofstee diagram to determine Vmax (10) and Km (11). Figure 4.8 and Figure 4.9 show
the saturation curves for α-galactosidase and β –galactosidase respectively and Figure
4.10 and Figure 4.11 are the Eadie-Hofstee diagrams for α-galactosidase and β –
galactosidase respectively.
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Figure 4.8 α-Galactosidase Saturation Curve.
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Figure 4.9 β-Galactosidase Saturation Curve.
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Figure 4.10 Eadie–Hofstee Diagram for α-Galactosidase at 27°C.
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Figure 4.11 Eadie–Hofstee Diagram for β -Galactosidase at 37°C.

From these plots, it is determined that Vmax is 395.69 EU/mg/min and Km is
0.7907 mM for α-galactosidase and Vmax is 681.73 EU/mL/min and Km is 1.4729mM
for β –galactosidase. As has been determined, temperature and pH influence the rate of
reaction. The GOS production reaction is carried out at 40°C, pH 6.5 – 7.2. The cellular
bound enzymes and the unbound β –galactosidase enzyme kinetics were determined
using these conditions however the α-galactosidase kinetics were determined at a much
lower temperature. The α-galactosidase is not the primary enzyme of interest however it
is important to see how temperature and pH will affect the reaction rate. Figure 4.12.
shows the relationship of temperature and pH on enzyme reaction rate for αgalactosidase. It is clear from this graph that enzyme activity increases with temperature
and pH has an optimum at pH 6.8 – 7.0. At 40°C the enzyme activity is 2.5 times the
activity at 25°C.
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Kinetic Effects of Temperature and pH
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Figure 4.12 Effects of pH and Temperature on α-Galactosidase at 0.01mg protein/mL
and 1mM PNPG.

4.6. ECONOMIC ANALYSIS
The costs for batch production of GOS by B. bifidum ATCC 700541 was
calculated using the β-galactosidase activity found in this study. Tzortzis et al. describe a
GOS process using 40% lactose in 100mM phosphate buffer with enough cell mass to
provide 850 EU in 100 mL of solution. The cells are recycled and used eight times with
10% loss of activity after each synthesis batch. This process yields 80-85% lactose
conversion with a GOS yield of 28 - 30%. These conditions provide the basis for
calculation of GOS production. Using the yield numbers from whey permeate reported
by Tzortzis a reactor needs to be batched with 8,600 U β-galactosidase /L to produce 130
- 150 g/L GOS. Dosing the reaction at this level the α-galactosidase levels in the mixture
are 7000 EU / 100L. The calculations include the potential for recycle of the cells with a
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loss ratio of 15% per cycle. Table 4.5 details the costs for GOS production using B.
bifidum ATCC 700541 and Table 4.6 details the costs for GOS production using unbound
enzymes. Prices for raw materials were obtained from common distributers of chemicals
and media components.

Table 4.5 Cost Details for Cell Bound Enzymes.
Cell Density
Media
Liters / kg Cells
(g/L)
Propagation
6.5
154
Enzyme
4.5
222

Media Cost
($/100L)
$ 402.30
$ 398.32

1.1 x 104
2.36 x 104

β –gal U/100L
GOS Batch
8.6 x 105
8.6 x 105

kg cells/100L
GOS Batch
78.2
36.4

kg cells/100L
GOS Batch
78.2
36.4

Cost ($/100L
GOS Batch)
$12,100
$8,055

α –gal U/kg

Cost Without
Cell Reuse
Propagation
Enzyme

β –gal U/kg

Cost With Cell
Reuse
Propagation
Enzyme

Table 4.6 Cost Details for Unbound Enzymes.
Activity per
Units per 100L
Enzyme
Unit
GOS Batch
β –galactosidase
681
1263
α –galactosidase
395
19

6.37 x 103

Cost ($/Unit)
$28
$17

Cost($/kg cells)
$ 618.92
$ 885.16
Cost ($/100L
GOS Batch)
$48,400
$32,220
α –gal U/100L
GOS Batch
2.32 x 105

Cost($/100L
GOS Batch)
$35,364
$325
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5. DISCUSSION

The ability to regulate human health through manipulation of the intestinal
microbiota has become an area of intense study. A particular area of study is the use of
prebiotics to selectively promote the growth of beneficial bacteria which are indigenous
to the lower intestines. Specifically, the use of galactooligosaccharides (GOS) has been
used to target species of Bifidobacteria.
Synthesis of GOS using β –galactosidase is presently the most feasible industrial
synthesis method due to the availability and cost of the starting material, lactose rich
cheese whey. β –galactosidase hydrolyzes lactose and transfers galactose to another
carbohydrate unit or water. GOS are formed when galactose are transferred to another
carbohydrate. Transfer to a water molecule results in complete hydrolysis and monomer
sugar units (Pazur 1954; Juers et al. 2001). It has been shown that in order to increase the
transgalactosylation reaction a high concentration of lactose must be present in solution
so that lactose is the preferred receptor for the galactose (Hsu et al. 2007).
GOS synthesis can be carried out using cellular bound enzymes or purified
enzymes. Research indicates that Bifidobacteria in the lower intestine show a preference
for GOS synthesized using enzymes from a homologous source (Rabiu et al. 2001).
Work done by Tzortis et al. show that Bifidobacterium bifidum NCIMB 41171 produces a
GOS mixture that promotes increased levels of indigenous Bifidobacteria growth as well
as increases in short chain fatty acid production.

The strain exhibited both β –

galactosidase and α –galactosidase which produced a unique mixture of GOS (Tzortis et
al. 2005).

We investigated B. bifidum ATCC 700541 using substrate analogs to

determine if it had similar enzyme activity characteristics. The findings were then
compared to the activity levels of purified enzymes from E. coli and A. niger to
determine the economic feasibility of further investigating B. bifidum ATCC 700541 as a
GOS producing organism.
The most cost effective media for cell culture would be a simplified media which
contained no complex vitamins, amino acids or protein fractions to enhance growth.
Previous work shows that Bifidobacteria are difficult to culture on minimal media
however, each strain of Bifidobacterium behaves differently under the same culture
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conditions. Results from our study show that B. bifidum ATCC 700541 does not grow or
has limited growth using minimal media. In an experiment performed over 8 days
cultures showed indications of growth on the 7th and 8th days of the experiment. Growth
was significantly less than 1 g/L which would not be cost effective considering the
volume that would be necessary to attain the number of cells that would be necessary for
GOS production.
Most Bifidobacteria require growth promoting factors termed “bifid” factors to
enhance growth. These factors include milk casein fractions, yeast extract, and complex
amino acid mixtures. Two media used by Tzortis et al. were selected to culture the cells.
B. bifidum ATCC 700541 responded very well to both the culture media. Each medium
contained different levels of yeast extract, meat extract and tryptone. The media were
termed “propagation medium” which yielded 6.5 g/L cell mass and 10.94 EU/g cells β –
galactosidase activity and “enzyme medium” which yielded 4.5 g/L cell mass and 23.6
EU/g cells β –galactosidase activity. The level of cell mass when compared to B. bifidum
NCIMB 41171 are in the same range or possibly higher; however, the level of β –
galactosidase activity is much lower.
Work by Astapovich and Ryabaya show a relationship between the types of sugar
in the culture medium and growth rate. There has also been work that has shown β –
galactosidase activity over time and its association with growth.

B. bifidum ATCC

700541 was cultured using different levels of both glucose and lactose on a commercially
prepared medium as well as the enzyme medium to compare growth on the sugars as well
as the enzyme activity during growth. Cells were cultured on the prepared medium with
only glucose at 3% and 5% the end samples were analyzed using HPLC. Each culture
had differing growth rates but in both cases there was an excess amount of glucose
present indicating that the sugar concentration was not the only factor in the increased
growth. In the “enzyme” medium, the culture had a glucose level held constant with
differing levels of lactose. The levels of lactose in the medium also showed an increase
in growth rate with an increase in concentration. Cells grown at 1% and 3% lactose were
then tested for enzyme activity and it is clear that at 1% the level of activity increases
with growth however at 3% the level remains fairly constant. The cells in the 3% culture
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reaches stationary phase sooner than the cells in the 1% medium and this could be a
reason for this observation.
The current method for GOS production is to use a purified enzyme extracted
from a fungal or bacterial source. The enzymes can only be used a single time since the
termination step in the GOS reaction is to heat denature the enzyme. To determine if B.
bifidum ATCC 700541 is an economically feasible strain to use for GOS conversion the
enzyme levels determined are compared to purified enzymes. The activity levels of an α
–galactosidase and a β –galactosidase were determined using kinetic assay
measurements.

Looking at the primary functioning enzyme, β –galactosidase , and

comparing the two sources of enzymes, bound and unbound, enzymes bound in B.
bifidum ATCC 700541 are as cost effective as the unbound enzymes. In order to be an
economically viable solution growing the cells needs to be more cost effective than the
enzymes. In order for this to be a possibility the costs were compared using data from
Tzortis et al. with 15% loss per cycle. Using this assumption in calculation the B.
bifidum ATCC 700541 becomes a viable option, with further research, as a candidate for
GOS conversion. Looking also at the α –galactosidase activity levels between B. bifidum
ATCC 700541 and B. bifidum NCIMB 41171, there is significantly more α –
galactosidase present in B. bifidum ATCC 700541. The overall effect this would have in
the GOS conversion reaction needs to be investigated.
To fully understand the potential of B. bifidum ATCC 700541 as an organism for
GOS production investigation into several factors is still necessary. Some of the factors
to determine viability for production include: determining what media components cause
increases in enzyme activity during cell culture and an evaluation of tradeoff between
enzyme expression and cell mass, metabolites in the culture media that cause growth
inhibition, gaining an understanding of how α –galactosidase activity present in B.
bifidum ATCC 700541 differs from α –galactosidase activity present in B. bifidum
NCIMB 41171 and what are the overall effects on the GOS mixture, determining if there
is any method of treatment for the cells which would open the cell wall to gain access to
β –galactosidase activity inside the cell, and verification of actual loss of activity levels
with each GOS production cycle.
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6. CONCLUSION

The investigation into the growth characteristics of this organism shows that B.
bifidum ATCC 700541 cannot be cultured on a medium that does not contain bifid
factors. The complex media presented in this work will culture B. bifidum ATCC 700541
with β –galactosidase activity. The studies indicate the following:
Sugar type and concentrations are important for growth and enzyme production in
the culture.
Nitrogen growth components type and concentrations are important for producing a
cell culture suitable for GOS production.
Under non-optimized growth conditions and measured enzyme activity levels using
the substrate analog ONPG, B. bifidum ATCC 700541 can be considered as an
organism for GOS production.
Optimization work should be done to find the right culture conditions which achieve
a balance between cell mass and enzyme activity level to produce a culture
economically capable of commercially producing GOS.
APPENDICES

APPENDIX A

DATA TABLES FOR STANDARD CURVES
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This appendix contains data used to generate standard curves for enzyme activity,
dry cell weight determination and sugar analysis by HPLC.

Table A.1 Absorption Data, 415nm for ONP Standard Curve.
[ONP]
(mM)
1
0.9
0.8
0.7
0.6
0.5
0.4
0.3
0.2
0.1

A1
1.286
1.1733
1.0414
0.88272
0.76014
0.63333
0.51119
0.37982
0.24653
0.12194

A2
1.2622
1.1759
1.0037
0.88213
0.76464
0.6407
0.50887
0.38021
0.24192
0.13044

A3
1.2829
1.1666
1.0389
0.89317
0.76916
0.64392
0.50764
0.37623
0.25914
0.12782

Mean
1.27703
1.17193
1.02800
0.88601
0.76465
0.63932
0.50923
0.37875
0.24920
0.12673

Standard
Dev
0.0129
0.0048
0.0211
0.0062
0.0045
0.0054
0.0018
0.0022
0.0089
0.0044

Table A.2 Absorption Data, 400nm for PNP Standard Curve
[PNP]
(mM)
0.5

A1
NA

A2
NA

A3
NA

Mean
NA

Standard
Dev
NA

0.4

2.0137

2.0351

2.0104

2.01973

0.01341

0.3

1.5049

1.5431

1.4598

1.50260

0.04170

0.2

0.99768 0.99464

1.0012

0.99784

0.00328

0.1

0.48963

0.49336 0.48776

0.00673

0.4803
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Table A.3 Turbidity Data, 910nm for Dry Cell Weight Standard Curve.
Cell
Density
(g/L)
7.5

OD1
2.63

OD2
2.62

OD3
2.62

Mean
2.62

Standard
Dev
0.01

5

2.25

2.25

2.24

2.25

0.01

4

2.05

2.06

2.05

2.05

0.01

3

1.77

1.78

1.78

1.78

0.01

2.5

1.56

1.57

1.58

1.57

0.01

2

1.38

1.37

1.38

1.38

0.01

1.5

1.14

1.15

1.14

1.14

0.01

1

0.78

0.80

0.77

0.78

0.02

0.5

0.44

0.43

0.45

0.44

0.01

0.25

0.21

0.23

0.20

0.21

0.02

0.1

0.11

0.10

0.12

0.11

0.01

Table A.4 Area Data for Lactose HPLC Standard Curve.
Concentration
(g/L)
10.21

Area 2
1208.413

Area 3
1209.311

Mean
1207.815

Standard
Dev
1.87

20.42

2353.257 2386.781

2397.956

2379.331

23.26

30.62

3570.181 3600.313

3610.357

3593.617

20.91

40.83

4770.027 4783.453

4787.928

4780.47

9.32

51.04

5997.861 6193.249

6258.378

6149.83

135.58

61.25

6990.694 7018.685

7028.016

7012.465

19.42

71.46

7803.779 7803.939

7803.993

7803.904

0.11

81.67

8409.885 8454.983

8470.016

8444.961

31.29

91.87

8910.779 8928.339

8928.339

8922.486

10.14

102.08

9393.803 9393.803

9465.711

9417.772

41.52

Area 1
1205.72
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Table A.5 Area Data for Glucose HPLC Standard Curve.
Concentration
(g/L)
5.13

Area 2
592.1505

Area 3
592.4736

Mean
591.935

Standard
Dev
0.67

10.27

1144.065 1157.854

1162.45

1154.789

9.57

15.4

1728.168 1740.501

1744.611

1737.76

8.56

20.53

2308.597 2312.179

4787.928

3136.235

1430.41

25.67

2917.307 3015.954

2313.373

2748.878

380.37

30.8

3479.81

3493.242

3497.719

3490.257

9.32

35.93

4078.241 4078.707

4080.105

4079.018

0.97

41.06

4607.423 4658.209

4675.137

4646.923

35.24

46.2

5135.346 5139.369

5151.436

5142.05

8.37

51.33

5774.066 5840.219

5862.27

5825.518

45.90

Area 1
591.181

Table A.6 Area Data for Galactose HPLC Standard Curve.
Concentration
(g/L)
Area 1
Area 2
5.3
587.5096 588.1352

Area 3
588.3437

Mean
587.9962

Standard
Dev
0.43

10.59

1146.574 1160.676

1165.377

1157.542

9.79

15.89

1736.779 1749.775

1754.107

1746.887

9.02

21.18

2324.521 2327.419

2328.385

2326.775

2.01

26.48

2939.6

3038.589

3071.585

3016.591

68.69

31.78

3505.491

3519.35

3523.969

3516.27

9.62

37.07

4108.457 4109.237

4111.578

4109.757

1.62

42.37

4641.737 4687.291

4702.476

4677.168

31.61

47.66

5158.222 5170.575

5174.237

5167.678

8.39

52.96

5814.234 5879.985

5901.901

5865.373

45.62

APPENDIX B

STATISTICAL ANALYSIS FOR STANDARD CURVES
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This appendix contains the statistical analysis of the data used to generate
standard curves for enzyme activity, dry cell weight determination and sugar analysis by
HPLC.

B.1.

Statistical Analysis of ONP Standard Curve
The assumptions of constant variance and normality made for ANOVA analysis

are verified in Figure B.1 and Figure B.2. The plot of the residuals in Figure B.1shows
random and independent distribution of errors. Linearity in Figure B.2 indicates the
residuals are normally distributed.

Figure B.1 Plot of Variation of Residuals for Each Concentration of ONP.
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Figure B.2 Normal Probability Plot for ONP Standard Curve.

Table B.1 ANOVA Statistical Analysis Output for ONP Standard Curve.

Regression
Residual
Total

Degrees of
Freedom
1
29
30

Absorbance 415

Sum of
Squares
18.95929753
0.003492948
18.96279048

Coefficients
1.281209437

Regression Statistics
Multiple R
0.999907896
R Square
0.9998158
Standard Error
0.010974812

Mean Squares
18.95929753
0.000120446

Standard
Error
0.003229283

F-Value
157408.5

Lower 95%
1.274604812

P-value

Upper 95%
1.287814062
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B.2.

Statistical Analysis of PNP Standard Curve
The assumptions of constant variance and normality made for ANOVA analysis

are verified in Figure B.3 and Figure B.4. The plot of the residuals in Figure B.3 shows
random and independent distribution of errors. Linearity in Figure B.4 indicates the
residuals are normally distributed.

Figure B.3 Plot of Variation of Residuals for Each Concentration of PNP.
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Figure B.4 Normal Probability Plot for PNP Standard Curve.

Table B.2 ANOVA Statistical Analysis Output for PNP Standard Curve.

Regression
Residual
Total

Degrees of
Freedom
1
11
12

Absorbance 400

Sum of
Squares
22.71102
0.005108
22.71613

Coefficients
5.023392222

Regression Statistics
Multiple R
0.999887556
R Square
0.999775124
Standard Error
0.021549756

Mean Squares
22.71102
0.000464

Standard
Error
0.022715438

Lower 95%
4.973395881

F-Value
48904.85

P-value
<<0.00001

Upper 95%
5.073388564

85
B.3.

Statistical Analysis of Dry Cell Weight Standard Curve
The assumptions of constant variance and normality made for ANOVA analysis

are verified in Figure B.3 and Figure B.4. The plot of the residuals in Figure B.3 shows
random and independent distribution of errors. Linearity in Figure B.4 indicates the
residuals are normally distributed.

Figure B.5 Plot of Variation of Residuals for each Cell Density.
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Figure B.6 Normal Residual Plot for Exponential Fit Dry Cell Weight Standard Curve.

Figure B.7 Normal Residual Plot for Linear Fit Dry Cell Weight Standard Curve.
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Table B.3 ANOVA Statistical Analysis Output for Dry Cell Weight Standard Curve
(Linear).
Degrees of
Freedom

Sum
Squares

Model

1

Residual
Total

of
Mean Squares

F-Value

P-value

2.5858120

2.58581

2847.803

<.0001

11

0.0099880

0.00091

12

2.5958000

Regression Statistics
R Square
0.999004
Standard Error
0.114113

Table B.4 ANOVA Statistical Analysis Output for Dry Cell Weight Standard Curve
(Exponential).
Degrees of
Freedom

Sum
Squares

Model

1

Residual
Total

of
Mean Squares

F-Value

P-value

248.19015

248.190

19059.70

<.0001

19

0.24741

0.013

20

248.43756

Regression Statistics
R Square
0.995026
Standard Error
0.019969

B.4.

Statistical Analysis of HPLC Standard Curves
The assumptions of constant variance and normality made for ANOVA analysis

are verified in Figure B.8, Figure B.9, and Figure B.10. The plots of the residuals in.
Figure B.8, Figure B.9 and Figure B.10 show random and independent distribution of
errors. Linearity in Figure B.11, Figure B.12, and Figure B.13 indicates the residuals are
normally distributed.
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Figure B.8 Plot of Variation of Residuals for Each Concentration of Lactose.

Figure B.9 Plot of Variation of Residuals for Each Concentration of Galactose.
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Figure B.10 Plot of Variation of Residuals for Each Concentration of Glucose.
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Figure B.11 Normal Residual Plot for Lactose.
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Figure B.12 Normal Probability Plot for Galactose.
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Figure B.13 Normal Probability Plot for Glucose.
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Table B.5 ANOVA Statistical Analysis Output for Galactose, Glucose and Lactose.
Degrees of Sum
Freedom
Squares
Lactose
Model
Residual
Total
Glucose
Model

of
Mean Squares

F-Value

P-value
<.0001

2
27
29

221148151
433560
221581712

110574076
16057.793

6886.007

1

82665096

82665096

36767.46

<.0001

Residual

28

62953

2248.3221

Total
Galactose
Model

29

82728049

1

83899719

83899719

33356.97

<.0001

Residual

28

70426

2515.2082

Total

29

83970145

R Square
Standard Error

Regression Statistics
Glucose
Lactose
0.998043
0.999239
126.719
47.416

Galactose
0.999161
50.152
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